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Chapter I 
GENERAL INTRODUCTION 
2 
Despite the unprecedented rapid progress of science technology in the final 
decades of the twenthieth century, the picture of malaria epidemiology has certainly 
not changed for the better, when compared to the beginning of this age. Many 
social, economical and political reasons may be implied, but it is a fact that 
medical science to date does not provide feasible tools for large scale prevention of 
disease and control of transmission in endemic regions. Most investigators in the 
field of malaria agree, that immunization would be the best option to prevent 
disease in endemic areas. Despite promising results of immunization experiments in 
the late sixties, and the design of several synthetic and recombinant vaccines 
thereafter, a protective vaccine is still not available (1-5). It is felt that for further 
progress in vaccine development, the behaviour of the parasite in the host and its 
susceptibility to host defence must be known in greater detail. 
The life cycle of Plasmodium 
Sporozoite induced malaria infection is acquired by the deposition of sporozoites in 
the skin by an infected mosquito which is taking a bloodmeal (Figure 1). 
Subsequently, these sporozoites are transported to the liver, by a still unresolved 
mechanism. Once inside a hepatocyte, sporozoites develop into exo-erythrocytic 
schizonts (EEF) in a time-span that is species-specific. After complete maturation, 
EEF will burst and thousands of merozoites are released into the circulation. The 
intra-erythrocytic proliferation of these merozoites and their periodic release into 
the bloodstream cause the cyclic pattern of fever, which is specific for malaria 
infection. Although most malaria cases are caused by mosquito bites, this is not the 
only way to acquire infection; especially in endemic regions, blood transfusion is 
also a well-known way of transmission. In this so-called blood-induced infection 
the parasite is transmitted as a merozoite, not requiring liver passage. In primary 
malaria infection the liver stage is essential for the parasite to be transformed from 
a rod-shaped sporozoite into ring-shaped asexual merozoites, which multiply by 
division and through which the parasites can differentiate further, to become game-
tocytes. Sexual multiplication takes place in the mosquito midgut, where male 
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2 SPOROGONY 
Figure 1. The life cycle of Plasmodium. 
Phase 1. Fertilization. A female Anopheles sucks a blood meal from an infected person. 
Gametocytes escape from red blood cells to become free gametes, male and female. The male 
gamete produces up to eight flagella in a sudden, violent exflagellation (I). These tear themselves 
free and swim off, each with a male nucleus attached. If a femalegametocyte is found, than 
fertilization (2) produces a zygote (3). This develops into the invasive ookinete (4), which bores 
into the stomach wall and becomes an oocyst. 
Phase 2. Sporogony: asexual development in the mosquito. The oocyst grows (1), then divides to 
produce thousands of invasive sporozoites (2). The mature cyst bursts (3) and the free sporozoites 
migrate through the body of the mosquito and invade her salivary glands (4). 
Phase 3. Hepatic schizogony; asexual development in the liver. When the mosquito feeds again 
sporozoites are injected into the blood They invade liver cells (I) and become hepatic trophozoites 
(2). These grow, then divide to produce thousands of invasive merozoites (3). The infected liver 
cells burst, releasing the merozoites into the blood (4). In Plasmodium vivax and Plasmodium 
ovale some sporozoites become hypnozoites (5) which lie dormant in liver cells, to develop months 
or years later and cause the illness to relapse. 
Phase 4. Erythrocytic schizogony asexual development in the blood. Merozoites invade red blood 
cells (1) and become erythrocytic trophozoites (2). These grow, and divide into 8 - 16 new 
merozoites (3). When mature the red cell bursts, merozoites are released (4), and the cycle starts 
again (5). As the disease progresses some merozoites develop into male or female gametocytes 
(6,7). These circulate but only develop further if they are taken up by a mosquito. (Reprinted by 
permission of The Wellcome Trust, from: Malaria (1991) page 13. A.J. Knell, editor, Oxford 
University Press, Oxford, UK.) 
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(micro-) and female (macro-) gametes, when present in the bloodmeal, fuse to form 
zygotes, and develop further into oocysts, containing thousands of sporozoites. 
When a mature oocyst ruptures, the sporozoites migrate to the salivary glands, 
ready for infection of a new host. 
From P. falciparum to P. berghei 
There are four malaria species which cause disease in humans, namely: P. falcipa-
rum. P. vivax. P. ovale and P. malariae. Of these P. falciparum, which is only 
transmitted in the tropics is the most dangerous. This parasite has the unique 
capability to cause cerebral malaria, a syndrome that is associated with high morta-
lity. From all mammals, only a few primate species are susceptible to P. falcipa-
rum. Since they are scarce and phenotypically rather close to Homo sapiens, 
possibilities are limited to perform thorough fundamental research in these animals. 
For decades, an important part of malaria research has been carried out with 
Plasmodium berghei. a rodent malaria parasite. In mice, rats and hamsters 
Plasmodium berghei induces a syndrome that resembles cerebral malaria in man (6-
8). With this parasite it is possible to create a condition which is called premunition 
and was first described by Sergent et al. in 1928 (9). The mice are resistant to an 
otherwise lethal superinfection, as long as asexual erythrocytic stages, adapted by 
the mutual host-parasite interaction sustain a low-grade parasitemia. Under 
experimental conditions this adaptation can result from a treatment of the host with 
sub-optimal doses of antimalarials, that controls the parasite density and hereby 
allows the establishment of immune effector responses (10). This premunition 
resembles the semi-immune condition to P. falciparum in adults living in 
holoendemic regions, sustained by a persistent low-grade parasitaemia (11, 12). 
Approaches to vaccine development 
The life cycle of the malaria parasite has six different stages, of which four appear 
in the vertebrate host (Figure 1). All of these stages could potentially be the target 
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of a protective vaccine. Nussenzweig et al. were the first to achieve protection in 
mice by immunization with irradiated sporozoites (1). Because of the apparent 
success, other groups tried to immunize some humans by the same procedure. 
Protection against P. falciparum malaria was achieved in eight of the fourteen 
volunteers reported in literature (2,3,13-16). Therefore, it was believed that the 
development of sporozoite-based vaccines could be a tool in malaria prevention. 
Many synthetic and recombinant DNA vaccines have been developed, but although 
some encouraging results were reached in immunization and challenge studies, 
none of the vaccine cancidates was able to provide a statistically significant protec-
tion in humans (4,17). 
Several experimental blood stage vaccines have been developed (18-20). Valero et 
al. claimed to have achieved considerable protection against disease in children, 
immunized with a synthetic merozoite vaccine (21). This vaccine is currently being 
tested in a double blind phase II trial in Tanzania. 
The induction of transmission blocking immunity is another option of malaria 
vaccine development. Although gametocytes do not cause disease, they are an 
important chain in the life cycle of the parasite. When male and female gametes 
fuse in the mosquito midgut, the resulting zygotes display antigens on their surface, 
which do not occur in other stages (22,23). Immunization of humans with these 
antigens may induce serum antibodies that are ingested by the mosquito, together 
with the gametocytes present in the bloodmeal. These antibodies inhibit further 
development of zygotes in the mosquito midgut and thus may prevent or reduce 
transmission of the parasite to new hosts. Rapid progress in research in this field is 
being obtained and field trials are expected to start in the near future . 
Immune response against liver schizonts 
In 1990 Mellouk et al. reported on the basis of a comparative study of the literature 
and of new experiments, that the protection achieved by immunization with 
irradiated sporozoites in humans, was dependent on the dose of irradiation (27). 
Volunteers immunized with P. falciparum sporozoites exposed to a high dose of 
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irradiation (200 Gy) did not seem to be protected on challenge with non-irradiated 
sporozoites, despite appropriate antibody response to sporozoite antigens. This had 
already been shown to be so in P. berghei malaria studies by Nussenzweig et al. in 
1969 (1). Mellouk et al. concluded that protection could only be achieved using 
sporozoites that were viable enough to penetrate hepatocytes and begin their trans­
formation to liver schizonts. This explains the lack of success of the sub-unit sporo­
zoite vaccines in humans. Unfortunately, immunization with irradiated sporozoites 
is not feasible for large scale vaccination programs. Maturation of liver schizonts 
from P. falciparum takes about ten days. During this period they may allow 
already existing specific Τ cell subsets enough time to mount an adequate immune 
response. Based on their results of P. berghei immunization experiments, Hoffman 
et al. and Tsuji et al. postulated the presence of malaria antigens on the surface of 
infected hepatocytes, which are recognized by CD8+ and CD4+ Τ cells, 
respectively (28,29). Therefore, this stage of the parasite's life cycle remains an 
attractive option for vaccine development. Exact knowledge of the interaction 
between host defence and developing liver schizonts may provide a feasible 
approach to intervention at this level. 
Outline of the studies presented in this thesis 
The studies presented in this thesis have been performed in order to clarify the role 
of inflammatory mediators in the development of liver schizonts. The maturation of 
liver schizonts from P. berghei in rats has been studied extensively since the early 
seventies. One of the findings has been, that rats from different strains showed 
different susceptibility to primary infection with sporozoites (30). Since these rats 
were immunologically naive to the parasite, we tentatively concluded that aspecific 
defence mechanisms were implied. Thus knowledge of the naive host's mechanism 
of defence against primary infection, became the goal of a new research project 
which included cell mediated responses such as phagocytosis, but also responses 
mediated by soluble factors such as cytokines and acute phase proteins. We investi­
gated the role of Kupffer cells, cytokines and acute phase proteins and verified 
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whether differences in non-specific defence mechanisms between rat strains 
correlated with their difference in susceptibility. Also, the effect of in vivo 
modulation of cytokine production on host susceptibility was evaluated. 
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CHAPTER II 
CYTOKINES INHIBIT THE DEVELOPMENT OF LIVER SCHIZONTS OF THE 
MALARIA PARASITE PLASMODIUM BERGHEI IN Г О 
Stephen G. S. Vreden, Maries F. van den Broek, Maria С Oettinger, Jan Peter Verhave, 
Joep H.E.T. Meuwissen, Robert W. Sauerwein. 
Published in: European Journal of Immunology 1992;22:2271-2275. 
ABSTRACT 
12 
The effect of induction of an acute phase response and its mediators on the 
development of liver schizonts of the rodent malaria parasite Plasmodium berghei 
was investigated in Brown Norway rats. Subcutaneous injection of turpentine oil 24 
hours or 5 minutes before inoculation of sporozoites resulted in 80 % and 35 % 
reduction of schizont development, respectively. Turpentine oil induced high 
plasma leves of IL-6. Intraperitoneal administration of IL-1, IL-6 or both, 
significantly reduced liver schizont development. This reduction was also present if 
IL-6 had been administered 24 h after sporozoite inoculation. Inhibition induced by 
IL-1 could be prevented by simultaneous administration of polyclonal anti-IL-6. 
Administration of polyclonal anti-IL-6 without IL-1 resulted in a 40 % increase of 
liver schizonts compared to control animals. We conclude that induction of an 
acute phase response during experimental Plasmodium berghei infections in Brown 
Norway rats, strongly inhibits liver schizont development and that IL-6 is a key 
mediator in this process. 
13 
INTRODUCTION 
Malaria infection can be acquired by the inoculation of sporozoites by an infected 
mosquito while it is taking a bloodmeal. Sporozoites are transported by the 
bloodstream to the liver and, after invasion of hepatocytes, they subsequently 
develop into liver schizonts (exo-erythrocytic forms, EEF). The number of EEF 
that develop upon intravenous administration of P. berghei sporozoites is known to 
be dependent on the susceptibility of the rat strain [1]. This phenomenon may be 
due to differences in acute phase response between the rat strains. 
A number of in vitro studies have demonstrated an inhibition of the development of 
EEF by acute phase reactants IL-1-α, IL-6 and C-reactive protein (CRP) and of 
IFN-γ on the development of EEF [2-8]. We investigated whether EEF develop­
ment in highly susceptible Brown Norway rats could be manipulated in vivo by 
induction of an acute phase response and by exogenous IL-1 and IL-6. 
MATERIALS & METHODS 
Rats 
Male Brown Norway (BN) rats were obtained from Harlan OLAC Ltd., Shaw's 
Farm, Blackthorn, Bicester, GB. Rats were housed in the central animal housing 
facilities and were fed a standard diet and acidified water ad libitum. Six to ten 
week old rats were used in all experiments. 
Production of P.berghei sporozoites 
Sporozoites of P.berghei (ANKA strain) were harvested from Anopheles gambiae 
mosquitoes, 21 days after infection and purified on a biphasic gradient containing 
urographin and FCS [9]. Live sporozoites (2.5 to 5 χ IO5) in 1 ml sterile Medium 
199 were injected into the tail vein. 
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Cytokines and antibodies 
Human recombinant IL-1-α, 5 χ IO6 U/mg, was kindly provided by Dr. P. 
Lomedico (Hoffmann La Roche, Nutley, New Jersey, USA [10]. Human 
recombinant IL-6 (rhIL6) 10' U/mg, was kindly provided by Dr. L. Aarden (Dept. 
of Auto-immune Diseases, Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service, Amsterdam, The Netherlands [11]. 
Polyclonal rabbit-anti-mouse-IL-6 was kindly provided by Dr. W. Buurman, 
Department of General Surgery, State University of Maastricht, The Netherlands. 
As a control, rabbit-anti-methylated BSA (mBSA) was used. 
Induction of acute phase response 
Rats were injected subcutaneously (s.c.) with 1 ml of turpentine oil. In rodents, 
this results in the production of several acute phase reactants, such as IL-1, IL-6 
[12] and CRP within a few hours, increasing to peak values around 24 hours after 
injection [13]. 
Cytokines were injected intraperitoneally (i.p.) diluted in 1 ml of sterile PBS at the 
following doses: 0.5 ^g for IL-1-α and 1 μg for IL-6. Control rats were injected 
with 1 ml of PBS, s.c. or i.p. 
Evaluation of the number of liver schizonts 
Forty-four hours after injection of sporozoites, rats were killed by cervical 
dislocation and livers were removed. Three 1 cm thick slices of the left liver lobe 
were fixed for 6 hours in Carnoy's fixative (60% ethanol, 30% chloroform, 10% 
glacial acetic acid) and subsequently transferred to 70 % ethanol. Paraffine sections 
(7 μτή) were made and stained with hematoxylin and eosin. The number of EEF 
per cm2 liver section from each rat was assessed microscopically by two 
independent investigators on coded slides. 
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B9 bioassay for IL-6 
At times indicated in Sect. 3, rats were bled from the tail vein in sodium citrate 
(final concentration 0.38%). Plasma samples were stored at -80°C. IL-6 was mea­
sured in plasma samples using the B9 bioassay [11]. Briefly, cells of the IL-6-
dependent murine hybridoma cell line (B9) were grown at a density of 0.1 -1 χ 
lOVml in Iscove's Modified Dulbecco's Medium supplemented with 10% FCS, 50 
μΜ ME (all Gibco), 40 ^g/ml gentamicin (Essex) and 8 U/ml rhIL-6. Before the 
assay, B9 cells were harvested by centrifugation and washed twice with IL-6-free 
medium. B9 cells were seeded at 5000 cells/200 μΐ in flat bottom wells (Costar 
Europe, Badhoevedorp, The Netherlands) in the presence of plasma samples in 
appropriate dilutions. Proliferation was measured by a [3H]Thymidine pulse during 
the last 16 hours of a 96-hours culture period. Per well, 3.7 χ IO4 Bq (Amersham 
Int., Amersham, GB; 0.7 χ IO8 - 1.1 χ IO8 MBq/mmol sp. act.) was added. 
Samples were tested in triplicate and were always related to a standard curve 
included in each experiment. One U/ml gives rise to half-maximal proliferation by 
definition. The sensitivity of the assay is 0.3 pg/ml. 
Statistical analysis 
All results were analysed for significance using the Wilcoxon rank sum test. 
RESULTS 
Effect of turpentine oil-induced acute phase response on the number of 
liverschizonts 
To investigate the effect of an acute phase response on the development of EEF we 
injected groups of five BN rats s.c. with 1 ml of turpentine oil at either 24 h or 5 
min before i.v. administration of 300 000 sporozoites. The control group received 
1 ml of sterile PBS s.c. 24 hours before injection of sporozoites. We measured 
plasma levels of IL6 in these 3 groups of rats from -24 h through +44 h (removal 
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of liver). Injection of turpentine oil at -24 h almost completely prevented the 
development of EEF (Figure 1A). Turpentine oil given at -5 min showed a 
moderate though still significant reduction when compared to control values (p < 
0.05). As early as 4 h after the administration of turpentine oil, high levels of 116 
are present in the circulation which reach peak values after 24 hours (Fig. IB). 
From the combined data it is concluded that the induction of an inflammatory 
response as reflected by circulating 116 significantly reduces the number of EEF. 
Maximal reduction is found when high levels of 116 are present at the time of 
sporozoite injection. 
LL: 
IL6 U/IJII (log »cal«) 
time ol turpentine oil Injection 
Figure I. A. inhibition of EEF development in BN rats (five per group), injected with turpentine 
oil at -24 h or -5 min. Rats were injected with 300 000 sporozoites at 0 h. The number of EEF in 
the control group, injected with PBS was 24 ± 41cm2 liver section Compared to the control group 
and to each other, the difference in EEF density was statistically significant (p < 0 05). B. 
Course of IL-6 levels (mean ± SEM) measured in plasma, drawn from these rats (-24 h = D , 
Oh = O, control = Δ). 
Effect of injection with IL-1 and/or IL-6 on the number of liverschizonts 
To investigate whether IL-1, IL-6 or a combination of IL-1 and IL-6 were able to 
replace a potent inflammatory stimulus like turpentine oil in its effect of reducing 
the number of EEF, we administered these cytokines to groups of 4 BN rats, 5 min 
before injection of 400 000 sporozoites. Injection of IL-1 + IL-6 or IL-6 alone 
gave an almost complete inhibition of EEF development (p < 0.05), whereas 
injection of IL-1 alone also reduced the number of EEF significantly (p < 0.05), 
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however, to a lesser extent than IL-6 (+ IL-1) (for both ρ < 0.05, Fig. 2A). The 
effect of IL-1 might be mediated through IL-6 (Fig. 2B) resulting in a later 
interference with the infection. These findings suggest that IL-6 is able to replace 
turpentine oil with respect to reduction of the number of EEF. 
ILS U/ml (log ecele) 
(a) 
J 
Injected cyloklnea 
hour· alter cytokine Infection 
Figure 2. a. Inhibition of EEF development in BN rats (four per group), injected i.p. with IL-6 (1 
μg), IL-J (0.5 \Lg), IL-6 and IL-1 (1 and 0 5 ßg respectively) or PBS I ml, all at -5 mm at -24 h 
or -5 min. Rats were injected with 400 000 sporozoites at 0 h. The number of EEF in the control 
group, injected with PBS was 28 ± 61cm2 liver section. Between all groups the difference in EEF 
density was statistically significant (p < 0 05) b. Course of IL-6 levels (mean ± SEM) measured 
in plasma, drawn from these rats (IL-6 = +, IL-1 = О , IL-6 + IL-1 = л , PBS = D J. 
Kinetic aspects of IL-6-mediated reduction of the number of liverschizonts 
Because our data on turpentine oil suggest that IL-6 can influence the development 
of liverschizonts in two phases of the infection (penetration and development), we 
injected groups of 4 BN rats with IL-6 at 10 min before, 6 h after and 24 h after 
administration of 500 000 sporozoites. Again, high plasma levels of IL6 around the 
time of infection resulted in 82% inhibition (p < 0.05), whereas high IL-6 levels 
later in the infection (after penetration) inhibited the number of EEF with 62% (+6 
hours, ρ < 0.05) and 35% (+24 hours, p=0.09) (Figure 3). 
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Figure 3 Inhibition of EEF development in 
BN rats (four per group), injected with 1 
lig of ¡L-6 as indicated Rats were injected 
i.v with 500 000 sporozoites at 0 h The 
mean number of EEF in the control group, 
injected with PBS was 34 ± 9/cm2 liver 
section Control vs t = 0, 6, or 24 h (ρ 
< О 05), t = 0 vs 6 or 24 h (ρ < О 05), 
t= б vs 24h φ < 0.06) 
Time of IL8 Infection (hours) 
In vitro inhibition of rat IL-6 by rabbit anti-mouse IL-6 antibodies. 
Since no polyclonal or monoclonal antibodies against rat IL-6 were available, we 
tested the capacity of a polyclonal rabbit-anti-mouse IL-6 to inhibit the biological 
activity of rat IL-6 in vitro. Therefore, we performed a bioassay with IL-6-
containing rat plasma (collected 24 h after turpentine oil injection) in the presence 
of serial dilutions of rabbit-anti-mouse IL-6. As a control, similar dilutions of 
rabbit-anti-mBSA were used. Table 1 shows that a complete inhibition of the 
biological activity of rat IL-6 can be achieved in vitro using this polyclonal an­
tiserum. Because anti-IL-6 had no inhibitory effect on the proliferation of a murine 
thymoma cell line (data not shown), we consider the observed inhibition of the B9 
bioassay, an IL-6-specific effect. 
In vivo neutralisation of the IL-1-induced reduction of EEF development by 
anti-IL-6 
If we consider IL-6 to be the key mediator in reduction of EEF, treatment of IL-1-
injected rats with anti-IL-6, should result in reversal of inhibition. Therefore, we 
injected 4 groups of 4 BN rats as follows: 1) IL-1 + anti-mBSA, 2) IL-1 + anti-
IL-6, 3) PBS + anti-mBSA, 4) PBS + anti-IL-6, followed by administration of 
250 000 sporozoites. Antisera (0.75 ml at a time) were injected i.v. both together 
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with and 4 hours after sporozoites IL-1 was given l.p. 4 hours before. IL-1 
reduced the number of EEF with 51% (p = 0.06), and this reduction could be 
partly reversed by anti-IL-6 (Figure 4) Moreover, injection of anti-IL-6 in control 
animals resulted in enhanced infection (140% compared to the control, ρ < 0.05). 
Table 1 In vitro inhibition of rat IL-6 by polyclonal rabbit anti-mouse IL-6. 
cpm in B9 assay 
Dilution anti-mBSA anti-mouse IL-6 
1/100 16217 611 
1/300 19711 2117 
1/1000 17646 4411 
1/3000 16127 5467 
Twenty-four hours after s с turpentine oil administration, plasma was coolected from five BN 
rats Pooled samples (IL-6 level 210 U/ml) were diluted 1/100 and IL-6 bioactivity was tested in 
the presence of either rabbit anti-mouse IL-6 or rabbit anti-mBSA (control) The standard curve 
included m this experiment, gave 9640 cpm for 1 U/ml IL 6 and 582 cpm as background value 
_ % inhibition 
Figure 4 Inhibition of EEF development in BN rats, 
injected at 0 h with IL-1 + rabbit anti-mouse IL-6, 
or rabbit anti-mouse IL-6 alone Administration of 
antisera (0 75 ml ι ν ) was performed at 0 h and 
at +4 h Rats were injected ι ν with 250 000 
sporozoites at 0 h The mean number of EEF in the 
control group, injected with rabbit anti-mBSA was 
17 ± 1/cm2 For the difference in EEF density in 
all groups, ρ = 0 06 
ILVanti-mBSA IL1*anli-IL-e anti-IL-e 
treatment schedules 
1 
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DISCUSSION 
Here we show for the first time that in vivo induction of IL-6 dramatically inhibits 
the development of Plasmodium berghei EEF. Injection of Brown Norway (BN) 
rats with turpentine oil 24 h before inoculation with sporozoites almost completely 
inhibited the development of EEF, as did an injection with IL-6 at the time of 
sporozoite inoculation. Both protocols induced high plasma levels (> 350 U/ml) of 
IL-6 at the time of infection. When comparable levels of IL-6 were established 
later in the infection (turpentine oil or IL-1 at the time of sporozoite injection, or 
IL-6 at 6 or 24 hours thereafter), less but still significant reduction of the number 
of EEF was observed. 
The kinetic experiment shows that IL-6 may inhibit penetration of hepatocytes by 
sporozoites, but that its major effect is directed towards intrahepatocytic 
development. Together with our observation that anti-IL-6 was able to reverse the 
IL-1-induced inhibition of development of EEF this suggests that IL-6 is a common 
mediator in inhibition of development of liver schizonts. 
The effect of anti-IL-6 treatment indicates that IL-1-induced inhibition of EEF 
development is mediated by IL-6. Our observation that anti-IL-6 itself increases the 
number of EEF, suggests that sporozoite inoculation induces IL-6 production. 
Whether this production is induced by sporozoites or due to bacterial contamination 
of the inoculum has not been investigated. 
Our in vivo data correspond well to previously described in vitro studies performed 
with sporozoites of Plasmodium voelii and murine hepatocytes. In this system it 
was demonstrated that IL-6 inhibits sporozoite penetration and development [3,14]. 
In the same studies it was shown that the hepatocyte and not the sporozoite is the 
target for IL-6. In vitro studies also showed that in addition to IL-6, both IL-1 and 
TNF-a [3,15] inhibit EEF development, however only when these cytokines are 
administered several hours before sporozoite inoculation. For the TNF-a effect 
nonparenchymal liver cells (Kupffer cells) also have to be present. Blocking studies 
with monoclonal antibodies showed that both TNF-a and IL-1 exert their effect 
through IL-6 [3,16]. IFN-γ was shown to inhibit the development of EEF in vitro. 
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It has been shown that IL-6 is a main inducer of the inflammatory and acute phase 
response in humans and rodents [12,17,18]. Its sustained effect on susceptibility of 
hepatocytes suggests intracellular production of a mediator, possibly an acute phase 
protein. Indeed, CRP is produced in cultures of human hepatocytes after 
stimulation with IL-1. It binds directly to the sporozoite, thus inhibiting the very 
early phase of infection [2]. 
In addition to acute phase reactants, reactive oxygen metabolites like hydrogen 
peroxide, superoxide anions [14], and nitrogen oxides [16], have been shown to act 
as effectors in reducing the number of EEF in vitro after incubation with IL-6 or 
TNF-a. Interestingly, blocking of nitrogen oxide synthesis in naive hepatocytes 
enhances the number of EEF, suggesting nitrogen oxides as a physiological defense 
mechanism of the hepatocyte. 
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CHAPTER III 
KUPFFER CELL ELIMINATION ENHANCES THE DEVELOPMENT OF 
LIVER SCHIZONTS OF PLASMODIUM BERGHEI IN RATS. 
Stephen G. S. Vreden, Robert W. Sauerwein, Jan Peter Verhave, Nico Van 
Rooijen, Joep H.E.T. Meuwissen, Maries F. Van Den Broek. 
Published in: Infection and Immunity 1993;61:1936-1939. 
26 
ABSTRACT 
We investigated the development of exoerythrocytic forms (EEF) of Plasmodium 
berghei in livers of normal and macrophage depleted Brown Norway rats. 
Macrophages were depleted by use of liposome-encapsulated dichloromethylene 
diphosphonate. Upon inoculation of sporozoites, macrophage depleted rats had 
significantly larger numbers of EEF than untreated rats. We also investigated the 
effect of macrophage impairment by silica treatment on the development of EEF 
and confirmed that silica induces a significant reduction of EEF development. 
Intravenous administration of silica induced high levels of interleukin-6 in plasma 
within a few hours. The seemingly contradictory results for EEF development may 
be explained by our previous observation that interleukin-6 strongly inhibits 
sporozoite penetration and EEF development in vivo. We conclude that in 
experimental infections with sporozoites, Kupffer cells inhibit rather than enhance 
EEF development. 
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INTRODUCTION 
Malaria infection can be acquired by the inoculation of sporozoites into the skin by 
an infected mosquito taking a bloodmeal. Sporozoites are transported by the 
bloodstream to the liver, in which they invade hepatocytes and subsequently 
develop into mature exoerythrocytic forms (EEF). The hepatic sinusoids are lined 
with endothelial cells and Kupffer cells. To invade the liver parenchyma, 
sporozoites have to pass through this cell-lining. The role of Kupffer cells in the 
clearance of sporozoites from the circulation and the subsequent development of 
sporozoites into mature EEF are subject to contradictory observations. Seguin et al. 
reported a minimal interaction in vitro of sporozoites with non-immune mouse 
Kupffer cells, which could readily ingest latex particles and Leishmania amastigotes 
(12). Observations made by Verhave et al. indicated that silica treatment caused a 
drastic reduction in the number of EEF, a result that led to the hypothesis that 
Kupffer cells are helpful in if not obligatory for the in vivo penetration of 
sporozoites into hepatocytes (18). Ultrastructural studies have shown that sporo-
zoites are present inside Kupffer cells from 10 min after inoculation into the portal 
vein and that they are able to escape Kupffer cells on the parenchymal side to 
subsequently invade hepatocytes (7). Finally, in a videomicroscopic study, 
Vanderberg and Stewart found that sporozoites both actively and passively enter 
Kupffer cells and also emerge from these cells (15). Whether Kupffer cells are 
essential for the establishment of a malaria infection needs further confirmation, 
since in vitro infection of isolated and plated primary hepatocytes has been 
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achieved (8). For investigation of whether depletion of functional macrophages has 
an effect on the penetration and development into liver schizonts of sporozoites, a 
recently developed method was used to selectively eliminate macrophages by allo-
wing them to ingest liposome encapsulated dichloromethylene diphosphonate 
(C12MDP). The liposomes are ingested by the macrophages and the drug is released 
into the interior of the cells as soon as the liposomal phospholipid bilayers are 
disrupted because of the influence of phospholipases present in the lysosomal 
compartments of the cells (16,17). After a single treatment, macrophages in the 
liver and spleen of rats are eliminated. Endothelial cells do not seem to be affected 
(1). We studied the effect of Kupffer cell elimination in vivo on the development 
of EEF by using this method. 
MATERIALS AND METHODS 
Rats 
Male Brown Norway rats were obtained from Harlan OLac Ltd., Shaw's Farm, 
Blackthorn, Bicester, United Kingdom. Rats were housed in our animal laboratory 
and fed a standard diet and acidified water ad libitum. Six- to ten-week-old rats 
were used in all experiments. These rats were chosen because of their high suscep-
tibility to sporozoite infection (7). 
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Production of Plasmodium berghei sporozoites 
Sporozoites of P. berghei (ANKA strain) were harvested from homogenized 
infected Anopheles gambiae mosquitoes and purified on a biphasic gradient 
containing urographin (Schering AG, Berlin, Germany) and bovine calf serum (5). 
Live sporozoites (3 χ IO5 to 5 χ 105in 1 ml of sterile phosphate buffered saline 
[PBS]) were injected intravenously (i.v.) 
Liposomes 
Multilamellar liposomes containing C12MDP (a kind gift from Boehringer GmbH, 
Mannheim, Germany) were prepared as described earlier (16). They were 
suspended in PBS in a concentration of 10 mg/ml. Rats were injected i.v. with 1 
ml/100 g of bodyweight. 
Silica 
Silica particles with a diameter of <5 μτη (Sigma Chemicals, St Louis Mo) was 
suspended in sterile PBS in a concentration of 17 mg/ml. Rats were injected i.v. 
with 1 ml/100 g of bodyweight. 
ED2 monoclonal antibody 
Mouse anti-rat macrophage monoclonal antibody ED2 was kindly provided by 
Christine Dijkstra, Department of Histology, Free University, Amsterdam, The 
Netherlands (3). 
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Evaluation of the number of liver schizonts (EEF) 
At 44 h after the injection of sporozoites, rats were killed by cervical dislocation 
and livers were removed. A few 1-cm-thick slices of the left liver lobe were fixed 
in Carnoy's fixative (60% ethanol, 30% chloroform, 10% glacial acetic acid) and 
subsequently transferred to 70% ethanol. Paraffin sections (7 μΐη) were stained 
with hematoxylin and eosin. The number of EEF per square centimeter liver 
section from each rat was assessed microscopically on coded slides. 
B9 cell bioassay for IL-6 
Rats were bled from the tail vein by use of sodium citrate (final concentration, 
0.38%) and plasma samples were stored at minus 80°C. Interleukin-6 (IL-6) was 
measured in plasma samples by the B9 cell bioassay (2). In Brief, the IL-6-
dependent murine hybridoma cell line B9 was grown to a density of 0.1 χ 105 to 1 
χ lOVml in Iscove's modified Dulbecco's medium (IMDM) supplemented with 
10% fetal calf serum (GIBCO Laboratories, Grand Island, NY), 50 μΜ ß-
mercaptoethanol (GIBCO), 40 μg of gentamicin (Essex, Amstelveen, The 
Netherlands) per ml, and 8 U of human recombinant IL-6 per ml. with a density of 
0.1-1 χ lOVml. Before the assay, B9 cells were harvested by centrifugation and 
washed twice with IL-6-free medium. B9 cells were seeded at 5,000 cells per 200 
μΐ in flat-bottom wells (Costar Europe, Badhoevedorp, The Netherlands) in the 
presence of plasma samples in appropriate dilutions. Proliferation was measured by 
use of a 3H-thymidine pulse during the last 16 h of a 96-h culture period. 
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3H-thymidine was added at 3.7 χ IO4 Bq per well (specific activity, 0.7-1.1 χ IO8 
MBq/mmol; Amersham International, Amersham, United Kingdom;) was added. 
Samples were tested in triplicate, and data were always compared to a standard 
curve included in each experiment. One Unit of IL-6 per milliliter gives rise to 
half-maximal proliferation by definition. The sensitivity of the assay is 0.3 pg/ml. 
Immunoperoxidase staining of cryostat liver sections for the demonstration of 
the successful elimination of Kupffer cells 
Immunoperoxidase staining was used to confirm the elimination of Kupffer cells 
from the liver in C12MDP- or silica-treated rats. Portions of removed livers were 
frozen in liquid nitrogen and stored at minus 80°C. Cryostat sections of 5 μπι were 
fixed in acetone and air dried. They were incubated for 45 min at room 
temperature with monoclonal antibody ED2 at a 1/400 dilution in PBS with 2% 
bovine serum albumin. After being washed thoroughly in PBS, the sections were 
incubated for 20 min with rabbit anti-mouse peroxidase (DAKO, Glostrup, Den­
mark) in a 1/200 dilution in PBS-1% rat serum. After another wash in PBS, the 
sections were incubated with 0.05% (wt/vol) diaminobenzidine (Sigma)-0.03% 
(vol/vol) hydrogen peroxide (E. Merck AG, Darmstadt, Germany) in TRIS-sucrose 
buffer. Finally, the sections were washed in PBS and counterstained with hema­
toxylin. In this procedure, Kupffer cells can be recognized as golden brown 
structures between the parenchymal cells (fig.l). 
Statistical analysis 
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Results were analyzed for significance by use of the two tailed Wilcoxon rank sum 
test. 
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Figure 1. Effect of 
liposomal CLJADP 
or silica treatment on 
Kupffer cells. 
Cryostat sections 
from rats injected 
with PBS (a), 
CL2MDP (b), or 
silica (c) were 
incubated with 
monoclonal antibody 
ED2 and rabbit anti-
mouse peroxidase. In 
the control rat, there 
was a normal distri-
bution of Kupffer 
cells (a; arrows), 
which were absent in 
the CL¡MDP-treated 
rat (b). The section 
from the silica-treated 
rat shows Kupffer 
cells engorged with 
silica (c; arrow). 
RESULTS 
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Effect of macrophage depletion by liposome encapsulated C12MDP on EEF 
development 
For investigation of the effect of Cl2MDP-induced elimination of macrophages on 
the development of EEF, Brown Norway rats were injected i.V. with either 
Cl2MDP-containing liposomes or an equal volume of sterile PBS. After 72 h, all 
rats were injected i.v. with 2 χ IO5 sporozoites. At 44 h later, livers were prepared 
for EEF assessment. Cl2MDP-treated rats developed significantly more EEF per 
square centimeter than control rats (P < 0.05; Table 1). 
Effect of silica treatment on EEF development 
Silica particles administered i.v. are absorbed by macrophages, a process that has 
been shown to impair the phagocytic function of these cells. To confirm previous 
observations indicating that this treatment led to significant reduction of EEF 
development, we injected Brown Norway rats with either a silica-suspension or 
sterile PBS. After 24 h, all rats were injected with sporozoites. Another 44 h later, 
livers were prepared for EEF assessment. We observed a significant reduction of 
EEF density in silica-treated rats(P < 0.05; Table 1). 
Measurement of circulating IL-6 after silica treatment 
Elimination of macrophages by Cl2MDP-containing liposomes and macrophage 
impairment by silica had opposite effects on EEF development. Since in vitro IL-6 
production by macrophages can be induced by silica (4) and also since preincu­
bation of hepatocytes with IL-6 has been shown to inhibit EEF development (11), 
we tentatively concluded that the reduction by silica of EEF development was due 
to the induction of IL-6 production. Therefore, plasma samples were taken from 
rats at 0, 6 and 24 h after theinjection of silica, C12MDP, or PBS. In control and 
CLjMDP-treated rats, IL-6 levels were below detection limits at all time points, 
whereas in silica-treated rats, IL6 levels were elevated in all samples (Fig. 2). 
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Table 1. Influence of liposomal C12MDP and silica on EEF development® 
EEF density in the presence of 
Expt injected 
sporozoites 
C1,MDP PBS Silica 
1 1.5 x 105 
2 5 χ 10s 
3 5 x 105 
5 45 ± 11 8 ± 7 
4 140 ± 3 5 34 ± 7 
5 nd 25 + 7 
nd < 0.05 
nd < 0 05 
4 + 1 < 0.05 
®In experiments 1 and 2, rats were injected ι ν with liposomal CIJADP After 3 days, sporozoites 
of Ρ berehei were administered ι ν In experiment 3, rats were injected ι ν with a silica 
suspension, 24 h prior to inoculation of sporozoites In all experiments, the control group received 
an equal volume of sterile PBS EEF density is expressed as the number of liver schizonts per 
square centimeter * number of rats per group ND, not done 
Silica PBS ICL2MDP 
200 
150 
100 
IL6 U/ml 
Figure 2 Plasma IL-6 levels after silica or 
Cl^iDP treatment Plasma was collected 
at the indicated times after ι ν admini­
stration of silica, PBS or CL^ÍDP IL6 
was measured in a B9 cell bioassay In 
PBS (control)- and in CL¡MDP-treated 
rats, no circulating IL-6 could be detected, 
whereas silica-treated rats had high levels 
of IL-6 within 6 h after treatment 
time (hours) 
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Discussion 
The elimination of Kupffer cells from the liver of BN rats by CL^MDP-containing 
liposomes leads to an increased number of EEF. This result sheds new light on the 
role of Kupffer cells in the initial phase of malaria infection. Sporozoites can only 
leave the bloodstream by penetration of the sinusoidal lining, which is formed by 
endothelial cells and Kupffer cells. The size of the fenestrae in the former probably 
does not allow sporozoite passage (20). There is evidence that sporozoites can enter 
Kupffer cells and subsequently leave these cells on the parenchymal side without 
being disrupted (7). The interaction of sporozoites of P. berghei with hepatocytes 
and with Kupffer cells in vitro shows a wide variety of patterns; sporozoites can 
actively enter and leave these cells and eventually destroy them (15). However, 
sporozoites can also be ingested and destroyed by Kupffer cells in vivo (5, 13). 
External killing of sporozoites during an interaction with macrophages has also 
been reported (15). The contribution of each of these phenomena to overall 
successful development of sporozoites in vivo has not been elucidated to date. 
Since in our experiments the elimination of Kupffer cells led to a fourfold increase 
in the number of EEF, it is very likely that external killing or ingestion and subse-
quent destruction by Kupffer cells is the fate of the majority of sporozoites in 
experimental infections. Another possibility is that Kupffer cells inhibit the 
maturation of schizonts indirectly by the production of IL-6. Penetration of a 
Kupffer cell may activate this cell and induce IL-6 production. Elsewhere we 
showed that IL-6 significantly inhibited EEF development even when administered 
24 h after sporozoite inoculation (19). 
The reductive effect of pretreatment with silica has been explained by the 
hypothesis that sporozoites can only enter the liver parenchyma by passing through 
Kupffer cells (18). When these cells are fully engorged with silica, they fail to 
internalize sporozoites. However, as we show here, phagocytosis of silica leads to 
IL-6 production within a few hours after administration. Therefore, the inhibitory 
effect of silica treatment on EEF development may be due to the induction of IL-6 
secretion. Sinden and Smith demonstrated a significant reduction of Kupffer cell 
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and EEF densities after silica treatment; they concluded that the reduction of 
Kupffer cell density was responsible for the lower EEF density (14). Our results 
with C12MDP treatment show that this is not the case. 
Treatment with liposomal CLjMDP may also affect other liver cells, such as 
hepatocytes, to some extent. Ultrastructural studies of the effecs on the liver are 
not available. However, it is not very likely that eventual hepatocyte damage will 
enhance schizont development. 
The IL-6 levels in silica-treated rats had decreased to low levels at the time of 
sporozoite inoculation. However, by that time hepatocytes had been exposed to 
high levels of IL-6 for many hours. Pied et al demonstrated that preincubation of 
hepatocytes with IL-6 in vitro prior to the inoculation of sporozoites strongly 
inhibits sporozoite penetration and EEF development (11). If IL-6 is the factor that 
leads to the inhibition of EEF development after silica injection, one might expect 
that the simultaneous injection of antibody to IL-6 would prevent the reduction of 
EEF development. Using a polyclonal rabbit anti-mouse IL-6 antibody, we could 
not demonstrate this effect (data not shown). This result may have been due to the 
inadequate neutralization of IL-6 because of the unknown kinetics of silica-induced 
IL-6 production or the presence of other as-yet-unknown inhibiting effector mecha-
nisms activated by silica treatment. 
The effect on hepatocytes of IL-6, which makes them resistant to sporozoite 
penetration and development, remains after the removal of IL-6. Several mediators 
have been shown to implement this prolonged refractoriness (9-11). Among these 
are acute phase proteins, reactive oxygen and L-arginine derivatives. Once induced, 
these mediators remain present for a prolonged time. 
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Abstract 
Brown Norway and Sprague Dawley rats are known to differ in their susceptibility 
to infection with sporozoites of Plasmodium berghei. as measured by the density of 
liver schizonts. Because of the known inhibitory effect of non-specific immu-
nomodulators on schizont development, we compared some aspects of the acute 
phase response in these two rat strains. LPS induced IL6 production was measured 
in supernatants of spleen cells and peritoneal macrophages of both strains. SD 
rats, which are the least susceptible to P. berghei sporozoites, showed significantly 
higher IL6 production by macrophages from both sources. When LPS was admi-
nistered in vivo, SD rats also had a significantly higher IL6 response. Hepatocytes 
from both strains were cultured in the presence of IL6. After three days of culture, 
a2-Macroglobulin concentrations in the supernatants of SD hepatocytes were much 
higher than those from BN rats. Kupffer cell depletion in both BN and SD rats 
was correlated with a significant increase in liver schizont density, but did not 
abrogate the difference in susceptibility. From these results we conclude that the 
higher cytokine production capacity of SD rats compared to BN rats, may contri-
bute to the difference in susceptibility to P. berghei sporozoites between these 
strains, but that other yet unknown factors are also involved. 
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Introduction 
Malaria infection is naturally acquired by the inoculation of sporozoites by an 
infected mosquito which is taking a bloodmeal. Sporozoites are transported by the 
bloodstream to the liver and after invasion of hepatocytes they develop into liver 
schizonts (exoerythrocytic forms or EEF). It has been shown that susceptibility to 
infection differs between rat strains; Sprague Dawley rats develop significantly 
lower numbers of EEF than Brown Norway rats (1). Elsewhere we reported that 
non-specific immune modulators such as cytokines, inhibit the development of EEF 
in vivo (2). The difference in susceptibility between the two rat strains therefore 
may be due to a difference in capacity to produce cytokines in response to 
inflammatory stimuli. We compared the ability of both rat strains to produce IL6 
upon LPS stimulation in vitro (spleen and peritoneal macrophages) and in vivo. We 
compared also the in vitro production of a2-Macroglobulin (a2~M) by isolated 
hepatocytes from BN and SD rats, since acute phase proteins have been shown to 
influence the development of liver schizonts, (3). Upon inflammatory stimuli the 
plasma-level of this protein in rats shows a more than fifty-fold increase, which is 
much more than e.g. C-reactive Protein (4). We also investigated whether pre-
incubation of sporozoites with a2-M has an inhibitory effect on their development 
into liver schizonts. Kupffer cells play an important role in the extracellular initial 
phase of malaria infection. They do so by killing and by phagocytosis of sporozoi-
tes, but also by secretion of cytokines which can inhibit EEF development even 
after the sporozoites have entered hepatocytes (5,6,7). Depletion of tissue 
macrophages leads to an increase of EEF density in BN rats (8). If only tissue 
macrophages are responsible for the difference in susceptibility between the two 
strains, this difference should be nullified by their depletion. This hypothesis is 
tested in the present study. 
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MATERIALS AND METHODS 
Rats 
Male Brown Norway (BN) and Sprague Dawley (SD) rats were obtained from 
Harlan Olac Ltd., Shaw's Farm, Blackthorn, Bicester, 0X6 OTP, UK. Rats were 
housed in our central animal housing facilities and were fed a standard diet and 
acidified water ad lib. Six to ten week old rats were used in all experiments. 
LPS 
Purified E. coli lipopolysaccharide, serotype 0111:B4 (Sigma Chemicals (Brussels, 
Belgium) was diluted in pyrogen-free PBS. 
Acute phase rat serum and a2-Macroglobulin 
Pooled serum collected from rats, 24 h after subcutaneous injection of turpentine 
oil was used as acute phase serum. Control serum was collected from the same 
rats, before administration of turpentine oil. a2-M was purified from acute phase 
serum as has been described previously (9). 
Cytokines and antibodies 
Human recombinant IL6 (rhIL6) 109 U/mg, was kindly provided by Dr. L. Aarden 
(Dept. of Autoimmune Diseases, Central Lab. Netherlands Red Cross Blood 
Transfusion Service, Amsterdam, the Netherlands) (10). Polyclonal rabbit-anti-
mouse-IL6 was kindly provided by Dr. W. Buurman, Dept. of General Surgery, 
State Univ. of Maastricht, The Netherlands. As a control, rabbit-anti-methylated 
BS A (mBSA) was used. 
Liposomes 
Multilamellar liposomes containing Dichloromethylene Diphosphonate (CLjMDP, a 
kind gift of Boehringer, Mannheim, Germany) were prepared as described earlier 
(11). They were suspended in PBS in a concentration of 10 mg/ml. Rats were 
injected intravenously with 1 ml/100 g bodyweight. 
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Production of P. berghei sporozoites 
Sporozoites of P.berghei (ANKA strain) were harvested from Anopheles gambiae 
mosquitoes, 21 days after infection and purified on a biphasic gradient containing 
urographin and FCS (12). Live sporozoites in 1 ml Medium 199 were injected into 
the tail vein. 
Isolation of spleen and peritoneal cells 
Spleen cells were obtained by homogenization of the whole spleen with a glass rod 
in a sieve, under sterile conditions. Erythrocytes were lysed using 0.16 M NH4C1 
in 0.17 M Tris/HCl buffer (pH 7.4). After three washes with Iscove's modified 
Dulbecco's Medium (IMDM) macrophage density was assessed by staining with 
peroxidase and DAB as a substrate. For both strains the cell suspension consisted 
of about 70 % macrophages. 
Peritoneal cells were obtained by rinsing the peritoneal cavity with sterile PBS. The 
aspirate was centrimgated and the cells (about 80 % macrophages) suspended in 
IMDM. 
In vitro IL-6 production of macrophages 
After isolation macrophages were seeded in 24 well culture plates at a density of 
106/well in 0.5 ml IMDM. The cells were cultured in an incubator (37° C, 5% 
C02). They were allowed to adapt for 24 h after which supernatants were replaced 
by fresh medium with or without LPS at a concentration of 1 ng/ml. After another 
24 h supernatants were aspirated and stored at -20° С until testing for IL-6 levels. 
In vivo stimulation of IL-6 production by LPS. 
BN and SD rats were injected i.p. with either 50 μg or 500 μg of LPS in PBS. 
Each group consisted of four rats. Just before and one, two and four h after LPS 
administration, rats were bled from the tail vein into sodium citrate (0.38 %). 
Plasma samples were stored at -20° С until testing for IL6 levels. 
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IL-6 bioassay 
IL-6 was measured in plasma samples using the B9 bioassay (10). Briefly, cells of 
the IL-6-dependent murine hybridoma cell line (B9) were grown at a density of 0.1 
-1 χ lOVml in IMDM supplemented with 10% FCS, 50 μΜ ß-ME (all Gibco, 
Grand Island, NY), 40 ^g/ml gentamicin (Essex, Amstelveen, The Netherlands) 
and 8 U/ml rhIL-6. Before the assay, B9 cells were harvested by centrifugation and 
washed twice with IL6-free medium. B9 cells were seeded at 5000 cells/200 μΐ in 
flat bottom wells (Costar Europe, Badhoevedorp, The Netherlands) in the presence 
of plasma samples in appropriate dilutions. Proliferation was measured by a [3H]-
Thymidine pulse during the last 16 hours of a 96-hours culture period. Per well, 
3.7 χ 10" Bq (Amersham Int.,Amersham,GB; 0.7-1.1 χ 108 MBq/mmol sp. act.) 
was added. 
Samples were tested in triplicate and were related to a standard curve included in 
each experiment. One U/ml gives rise to half-maximal proliferation by definition. 
The sensitivity of the assay is 0.3 U/ml. 
In vitro stimulation of hepatocytes with IL-6. 
Liver cell suspensions from BN and SD rats were prepared by in vivo perfusion 
with collagenase solution, as described by Princen et al (13). After centrifugation 
cells were suspended in Williams Medium E (Flow Laboratories) containing 10 % 
foetal calf serum, 2mM L-glutamine (Flow Laboratories), 20 mU/ml Insulin 
(Actrapid, Novo Nordisk, Zoeterwoude, The Netherlands)), 50 nM Dexamethasone 
(Organon, Oss, The Netherlands), 2.5 ^g/ml Amfotericine В (Squibb, Woerden, 
The Netherlands), 100 /ig/ml Vancomycin (Lilly, Nieuwegein, The Netherlands) 
and 50 μg/ml gentamycin (Essex, Amstelveen, The Netherlands). Cells were 
counted and viability was determined by Trypan Blue exclusion. At densities of 1 χ 
lOVml they were seeded in 24 well culture plates (Costar Europe, Badhoevedorp, 
The Netherlands) in the presence or absence of 2000 U/ml rhIL-6. After three days 
of culture, supernatants were aspirated and frozen at -20° C, until measurement of 
a2-M concentration. 
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Measurement of a2-Macroglobulin in culture supernatants. 
a2-M concentration in supernatants was determined by a direct ELISA with avidin-
HRP using the IgG fraction of the monospecific polyclonal antibody (14). 
Evaluation of the number of schizonts 
44 hours after injection of sporozoites, anaesthesized rats were killed by cervical 
dislocation and livers were removed. Livers were fixed in formaldehyde and 
paraffine sections (7 μτα) were prepared and stained with hematoxylin and eosin. 
The number of EEF per cm2 liver section from each rat was assessed microscopi­
cally by two independent investigators on coded slides. 
Results 
Comparison of IL6 production of BN and SD rats in vitro and in vivo. 
11-6 is known to inhibit EEF development in vitro and in vivo. We hypothesized 
that the difference in susceptibility to infection between SD and BN rats may be 
explained by differences in IL-6 production capacity. Therefore, we compared in 
these two rat strains, the capacity to produce IL-6 upon LPS stimulation in vivo 
and in vitro. Both spleen and peritoneal macrophages from SD rats showed a much 
higher IL-6 production in vitro than BN rats (table 1). Also, SD rats had higher 
plasma levels of IL6 after in vivo administration of LPS. In both strains the highest 
IL-6 concentration was measured at 2 h. after LPS administration (fig 1). Thus in 
vitro as well as in vivo SD rats are better producers of IL-6 upon LPS stimulation 
than BN rats. 
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Table 1 Macrophages from BN and SD rats differ in their capacity to produce IL-6 
LPS concentration in super- Origin of macrophages 
natant 
Spleen Peritoneum 
ng/ml BN SD BN SD 
О < <
4 
< < < < < < 
0 01 
0 1 
1 
3,750 
8,500 
7,500 
15,000 
18,750 
25,000 
3,000 
4,750 
4,750 
11,250 
13,750 
15,000 
Macrophages from spleen and peritoneum were cultured for 24 h with or without the indicated 
concentrations of LPS IL-6 levels in supernatants, expressed in ¡J/ml, were measured in triplicate 
by use of the B9 cell bioassay Standard deviation was always < 15% @ below detection level 
10000 
1000 = 
IL6 (U/ml) logscale 
100 
BN-50 ug 
SD-50 ug 
time in hours 
—l— BN-500 ug 
- B - SD-S00 ug 
Figure 1 Course of plasma IL-6 levels 
after LPS injection in BN and SD rats 
Male 6-wk-old Brown Norway (BN) and 
Sprague Dawley (SD) rats, 5 per group, 
were injected ι ρ with 50 or 500 μ# of 
LPS, dissolved in 1 ml of PBS Blood was 
collected at the indicated times and plasma 
IL-6 levels were measured by use of the B9 
cell bioassay At both concentrations of 
LPS IL-6 levels in SD rats were 
significantly higher than in BN rats at all 
time points (p < 0 05) 
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Comparison of a2-Macroglobulin production of BN and SD rats in vitro. 
In rats, a2-M levels show the most prominent response upon inflammatory stimuli 
(4). It has been shown that pre-incubation of sporozoites with acute phase serum 
inhibits schizont development (3). The role of endogenously produced CRP in this 
inhibition has recently been questioned (16). We investigated whether in addition to 
higher IL6 production a2-M production capacity was also higher in SD rats. 
Hepatocytes from rats of both strains were isolated and cultured in the presence or 
absence of IL-6 for 3 days, and supernatants were assayed for a2-M concentration. 
Table 2 shows that the hepatocytes from SD rats produced much higher quantities 
of a2-M upon stimulation with IL-6. 
Table 2 in vitro production of a2-Macroglobulm by hepatocytes from BN and SD rats. 
or2-Macroglobulin (ng/ml) 
IL-6 (U/ml) 
0 
2000 
BN 
< 50 
367 
SD 
80 
1694 
Hepatocytes from BN and SD rats were cultured in triplicate with or without IL-6 for 3 days in the 
presence of insulin and dexamethasone (see text) Supernatants were assayed m duplicate for a2-
M Standard deviation was always < 20% 
Effect of pre-incubation of sporozoites on EEF development. 
After we had demonstrated the difference in production capacity of oil-
Macroglobulin between the two rat strain, the relevance of this finding for schizont 
development had to be investigated. Three experimental groups, each containing 
five Brown Norway rats were used. The rats from each group were injected i.v. 
with sporozoites which had been incubated for 30 min at 37° С in normal rat 
serum (I), acute phase serum (II), or purified a2-M, diluted in normal rat serum, 
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final concentration 105 /xg/ml (III). Each rat received 1 χ IO5 sporozoites. Rats 
from group I had the highest number of liver schizonts (Table 3). The inhibition 
accomplished by preincubation with acute phase serum was the strongest, but also 
preincubation with a2-M reduced the number of developing schizonts significantly. 
Effect of macrophage depletion on EEF development. 
Monocytes and macrophages are not only important sources of IL-6, but liver 
macrophages (Kupffer cells) may also inhibit EEF development by internalization 
and digestion of sporozoites (6). In BN rats elimination of Kupffer cells leads to an 
increase of EEF density (8). If the low susceptibility of SD rats to infection with R 
berghei sporozoites is mainly due to IL-6 production of Kupffer cells and/or 
increased destruction of internalized sporozoites, selective elimination of macrop­
hages should not only increase the number of EEF in SD rats, but also neutralize 
the difference with BN rats which underwent the same treatment. From both strains 
five rats were injected i.v. with liposomal C12MDP, one ml per 100 g of body-
weight. Control rats received equal volumes of sterile PBS. After three days all 
rats were injected with 1.2 χ IO5 sporozoites. In control rats the well documented 
difference in susceptibility was demonstrated (p < 0.05). This difference however, 
Table 3. Acute phase serum and a2-Macroglobulin inhibit EEF development 
Pre-incubation η EEF density 
normal serum 5 12 4 ± 2 5 
acute phase serum 5 3 ± 1 
a2-Macroglobulin 5 6.4 ±1.7 
Kruskall Wallis ρ < 0.003 
Before i.v injection into BN rats, sporozoites were incubated during 30 min at 37° С with either 
normal serum, acute phase serum or a2-M Each rat received 1 χ IO5 sporozoites EEF density is 
expressed as the number of liver schizonts per cm2 
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however, was not abolished after depletion of macrophages, although both in SD 
and BN rats a statistically significant increase of EEF density was accomplished in 
CL2MDP treated rats (table 4). 
Table 4 Influence of liposomal C12MDP on EEF development in BN and SD rats. 
Rat strain 
BN 
SD 
ρ-value 
η 
5 
5 
EEF 
C12MDP 
44 ± 7.7 
17 ± 3.8 
< 0.05 
density 
PBS 
16.4 ± 4.8 
3 ± 1.5 
< 0.05 
p-value 
< 0.05 
< 0.05 
Rats were injected ι ν with liposomal CI JAD Ρ After 3 days 1 2 χ 10s sporozoites of Ρ bershei 
were administered ι ν Control groups received equal volumes of sterile PBS. EEF density is 
expressed as the number of liver schizonts per cm2 
Discussion 
This study has been carried out to investigate whether the different susceptibility to 
P. berghei infection of BN and SD rats could be explained by differences in the 
acute phase response. Our results show that macrophages from SD rats, which are 
less susceptible to infection with P. berghei sporozoites, have the highest IL-6 
production upon stimulation with LPS in vivo and in vitro. IL-6 is known to inhibit 
sporozoite penetration and/or EEF development (2,7,17). In vitro studies from Pied 
et al. and also our own previous in vivo experiments indicate that the effect of 
cytokines such as TNF and IL-1 is mainly exerted through induction of IL-6 
production (2,18,20). Even IL-6 however, has no direct effect on sporozoites (7); it 
induces other acute phase reactants such as acute phase proteins, reactive oxygen 
metabolites and nitric oxide, all of which have been shown to inhibit sporozoite 
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penetration and/or EEF development (7,19,20,21). 
The in vitro production of a2-M by IL-6-stimulated hepatocytes is also much higher 
in SD than in BN rats. Together with a stronger IL-6 response, this leads to an 
amplification of the acute phase response in SD rats. 
Elsewhere we reported that in BN rats intravenous administration of polyclonal 
anti-IL-6 could not only antagonize the reductive effect of IL-1, but also by itself 
causes a significant increase in EEF numbers in comparison to control animals, 
suggesting a role for endogenous IL-6 in our experimental system (2). We could 
not induce this increase through neutralisation of IL-6 in SD rats (data not shown). 
This is possibly due to the amplifying mechanism through which a relatively low 
plasma concentration of IL-6 is sufficient to induce an adequate production of acute 
phase proteins. 
Recently, We demonstrated that depletion of Kupffer cells leads to a sharp increase 
in EEF density (8). It was concluded that Kupffer cells are mainly involved in 
elimination of sporozoites. These experiments had been carried out in BN rats. In 
the present study we investigated the contribution of Kupffer cell activity to the 
observed different susceptibilities of the two rat strains. The results show, that 
although macrophage depletion in SD rats leads to a significant increase in EEF 
density, they remain less susceptible than similarly treated BN rats. This indicates 
that although the cytokine production by tissue macrophages is correlated with 
susceptibility to infection with P. berghei sporozoites, their depletion (mainly from 
spleen and liver) is not sufficient to eliminate the difference in susceptibility 
between the two strains (22). Other inhibitory mechanisms may be implicated, such 
as the suitability of the host's hepatocytes in which the sporozoites develop into 
mature schizonts. Schizont development can not only be inhibited by prevention of 
sporozoite penetration, but also after succesful hepatocyte invasion (2,7). The suit-
ability of a hepatocyte as a host cell for EEF development may therefore be 
determined by e.g. the extent to which it can be stimulated to produce reactive 
agents. As for a2-M, of which we show the inhibitory effect on EEF development 
in this study, the difference in production capacity between the rat strains supports 
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this theory. Thus, the lower susceptibility of SD rats may be explained at several 
levels of the acute phase response. Macrophages respond to lower doses of LPS, 
they produce more IL-6, and hepatocytes produce more acute phase proteins upon 
IL-6 stimulation. Because of this progressively amplifying system it is not possible 
to eliminate the difference in susceptibility between the strains by incomplete 
inhibition of just one factor in the cascade of the acute phase response. 
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THE ROLE OF KUPFFER CELLS IN THE CLEARANCE OF MALARIAL 
SPOROZOITES FROM THE CIRCULATION 
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In the past decade, one of the most intriguing subjects in understanding the mecha-
nism of malaria infection has been explanation of the role of Kupffer cells. These 
liver cells, which play an important part in the body's defense against infection, 
seemed to have an essential supportive role in the homing of sporozoites. Do 
Kupffer cells favor the establishment of primary malaria infection? Extensive 
research has revealed much, but still not everything we always wanted to know 
about the sporozoite-Kupffer cell affair. 
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I. Introduction. 
Malaria infection in mammals starts with the inoculation of sporozoites in the host 
skin by an infected female mosquito, while taking a bloodmeal. Sporozoites are 
then transported to the liver, where they are cleared from the blood circulation. 
Inside hepatocytes they develop into schizonts, which after maturation release 
thousands of merozoites into the circulation. On first sight, the homing and 
development schedule is quite simple and straightforward. There are however 
several aspects in this part of the cycle, that are still incompletely understood. For 
instance, the ways in which sporozoites enter the blood circulation from the skin 
tissues, are transported to the liver, and how they pass the defensive sinusoidal 
lining, in order to enter the liver parenchymal cells for further development. 
Sporozoites themselves are not pathogenic. The liver stage is essential for develo-
ping merozoites, which enter erythrocytes and cause disease. Exact knowledge of 
the mechanism of sporozoite transport, clearance from the circulation and subse-
quent intrahepatic maturation, may therefore disclose possibilities to block the cycle 
at this level, providing an instrument to prevent disease. This review focusses on 
research that has been performed, in order to clarify the mechanisms of sporozoite 
transportation from the inoculation site to the liver sinusoids, clearance from the 
circulation and subsequent intrahepatocytic maturation. 
II. Deposition of sporozoites in the skin. 
To obtain a bloodmeal, mosquitoes have to probe their proboscis into a skin 
capillary. Sporozoites however are not necessarily inoculated inside the vessel. 
Ponnudurai et al. demonstrated the deposition of P. falciparum sporozoites in the 
interstitium of a mouse skin that had been used as a membrane for artificial 
feeding1. Previously, Ungureanu et al. produced infections in human volunteers 
who were injected intradermally with Plasmodium vivax sporozoites2. According to 
several investigators, who have employed different investigational methods, the 
median number of sporozoites inoculated by a single mosquito is about 25'4. This 
rather low number of sporozoites that is necessary to obtain infection, suggests a 
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very high efficiency of sporozoite transport Ponnudurai et al demonstrated that 
sporozoites disappear within one or two hours from the inoculation site1 They 
suggested the prefered route of migration to be the lymphatics, rather than the 
blood capillaries There is however no evidence for either possibility 
III. Tracing sporozoites after inoculation. 
Sporozoites are most likely to be cleared in the microcirculation of the spleen and 
the liver However, only clearance in the latter is of use for further development 
Verhave et al assessed the circulation time of ι ν injected Ρ berghei sporozoites, 
by subinoculation of small blood samples from the initial rat into fresh young rats, 
which subsequently did or did not develop parasitaemia5 They demonstrated, that 
the circulation time can be prolonged from 25 minutes to at least 1 hour, by 
treatment with silica particles These are internalized by Kupffer cells (and other 
macrophages), which hereby become incapacitated These results led to the 
conclusion that phagocytes are involved in the clearance of sporozoites from the 
circulation Danforth et al and Sinden and Smith reported simultaneously their 
results with administration of sporozoites in perfused livers via a canule in the 
portal vein67 Both research groups found that the majority of sporozoites were 
cleared from the circulation in their first passage through the liver, 95% and 67% 
respectively The latter group also demonstrated that most of the sporozoite uptake 
in the liver was due to mechanical trapping 
The role of the spleen in primary malaria infection, remains subject to a discre­
pancy, Verhave et al found no difference in the number of developing liver schi-
zonts of Ρ berghei between splenectomized and sham-operated rats5 Using a DNA 
probe, Ferreira et al demonstrated, that at 5 hours after ι ν injection of Plasmodi­
um berghei sporozoites, the amount of parasite DNA in the spleen of Brown 
Norway rats, was more than tenfold that of the liver8 After 44 hours, parasite 
DNA had disappeared completely from this site, suggesting destruction by macrop­
hages At this time the amount of parasite DNA in the liver had increased more 
than 200-fold, reflecting parasite proliferation In the same study it was shown that 
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splenectomy, ten days prior to inoculation of sporozoites induced an eight-fold 
increase of parasite DNA in the liver. Finally, it was found that there was no 
statistically significant difference in schizont density between rats inoculated in the 
portal or the tail vein. It was concluded that large numbers of viable sporozoites 
are cleared from the circulation by the spleen. These results are highly in contrast 
with the splenectomy results of Verhave et al. A possible explanation could be that 
in their experiments, sporozoites were injected only two days after operation. At 
this time in both groups there may still be an effect of surgery-induced cytoki-
naemia, which leads to production of acute phase proteins by hepatocytes9. This 
may neutralize the effect of splenectomy. 
IV. The cell lining of liver sinusoids. 
It has long been debated whether sporozoites enter hepatocytes via Kupffer cells or 
whether they are able to squeeze themselves through the narrow fenestrae of 
endothelial cells. Liver sinusoids are lined by a unique type of endothelial cells, 
perforated by fenestrae of about 0.1 μπι in size. Throughout the lining, few 
Kupffer cells are interspersed between the endothelial cells, to which they maintain 
a close contact, without open gaps10· ' '. Although endothelial cells are capable of endocy-
tosis of small particles, they were never shown to internalize microbes12. Sporozoi­
tes, with an average diameter of 1 μπι, may not be able to penetrate the endothelial 
cell fenestrae. The only other way to reach the hepatocytes is passage through 
Kupffer cells. Several investigators have studied the interactions between sporozoi­
tes and sinusoidal cells in vivo and in vitro, with sometimes contradictory results. 
Their work will be discussed below. 
V. Ultrastructural observations at the level of liver sinusoids. 
Meis et al. presented microscopical observations regarding clearance of P. bergei 
sporozoites from the sinusoids13. It was demonstrated that sporozoites adhere to the 
Kupffer cell pseudopods, which through extension completely internalize the sporo-
zoite. Pseudopods with underlying accumulation of microfilaments, were observed 
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in different stages of surrounding the sporozoites (figure 1). Therefore they 
concluded that sporozoite-Kupffercell interaction is a process of phagocytosis rather 
than active penetration. The presence of sporozoites in Kupffer cells could only be 
demonstrated within the first 30 min after inoculation in the portal vein. At 45 min 
only degenerated sporozoites were observed. In later publications, Meis et al 
presented observations of sporozoites leaving Kupffer cells and entering hepatocy-
tes14,15. This established the role of Kupffer cells as a possible gate for sporozoites 
to reach hepatocytes. Using a different fixation procedure, Shin et al. found that 
within several minutes after i.v. injection, the majority of sporozoites was inside 
Kupffer cells, but unlike the observations of Meis et al., these sporozoites were all 
in a process of phagocytic destruction; morphologically intact sporozoites were 
only detected inside hepatocytes16. Therefore they concluded that sporozoites pass 
through the fenestrae of endothelial cells and cross the space of Disse towards the 
hepatocytes. The results of these two studies seem conflicting. A fact is that Shin et 
al. used Sprague Dawley rats, which have a much lower susceptibility to infection 
with Plasmodium berghei sporozoites than Brown Norway rats, which were used 
by Meis et al.17. Whether the differences are based on Kupffer cell (in)-tolerance to 
sporozoites is unknown. Possibly, in Sprague Dawley rats, only the most motile 
sporozoites, which leave the Kupffer cells immediately after phagocytosis, can 
escape from destruction. 
Cerami et al. studied sporozoite-hepatocyte interaction in the space of Disse18. 
Using several synthetic peptides, representing different parts of the CS protein, 
they demonstrated that the RH region from P. falciparum as well as from R 
berghei sporozoite surface protein is the ligand through which sporozoites bind to 
specific receptors on the hepatocyte. It was shown that these sporozoite receptors 
were located on the basolateral domain of the hepatocyte plasma membrane, facing 
the space of Disse (figure 2). The latter observations demonstrate for the first time, 
that the highly preserved RII region is essential for sporozoite infectivity and may 
provide a new strategy for drug or vaccine development. 
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Figure 1. Electron microscope pictures of a morphologically intact sporozoite inside a Kupffer 
celi. 
A. This picture shows the very close contact of the electron-light Kupffer cell protrusion without 
organelles, with the hepatocyte. The sporozoite is localized in an endocytic vacuole and in this 
oblique section its curved nature is well shown through the sub-pellicular microtubules (arrows). 
B. The sporozoite is in a process of leaving The kupffer cell protrusion and entering the hepatocy-
te. Cytoplasmic extensions of the Kupffer cell remain visible at both sides of the sectioned sporo-
zoite. C. This inset shows the apical tip of the sporozoite with its apical rings (arrows). The 
parasite is completely surrounded by hepatocytic cytoplasm. 
Reprinted by permission from Parasitology, 86, 231-242. 
Copyright 1983 Cambridge University Press. 
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Figure 2. The CS Binds to Microvilli of Human Hepatocytes in the Space of Disse. 
Aggregates of CS molecules bind to hepatocyte microvilli within the space of Disse (arrows) and 
to the lateral membranes of adjacent hepatocytes (arrowheads), The hepatocyte surfaces exposed 
to the bile canaliculi (ВС) and to the sinusoidal mambrane of endothelia (EC) are not labeled. H 
designates hepatocyte, N designates hepatocyte nucleus, S designates sinusoid, and E designates 
erythrocyte. Scale bar = 1 pm. Reprinted with permission from Cell 70, 1021-1033. Copyright 
Cell press 1992. 
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VI. Videomicroscopic observations of sporozoite-macrophage interactions. 
The development of video-microscopy made it possible to observe the interaction of 
sporozoites and macrophages in real time. Vanderberg et al. published two studies 
on their observations of P. berghei sporozoite interaction with peritoneal 
macrophages from rats and mice14·20. Almost all possible interactions were 
observed: sporozoites gliding over the macrophage surface without being destroyed 
or internalized, external killing of sporozoites by macrophages to which they 
became attached, and active phagocytosis followed by sporozoite escape and most 
often death of the macrophages. But even when the sporozoite did not escape, it 
remained intact inside the cell for up to one hour. Sporozoites were also observed 
to actively penetrate and leave the macrophage in a 'needling' fashion, which 
would probably lead to destruction of the cell. Interestingly, in the presence of anti-
sporozoite antibodies, only phagocytosis was observed. These observations 
corroborate previous findings of Meis et al. that presence of sporozoites inside 
Kupffer cells does not necessarily lead to their destruction, but that they are still 
capable of evading the macrophage and penetrating another cell, which may be a 
hepatocyte15. An asset of videomicroscopy may be, that it allows observation of the 
very rapid process of active penetration. It should be reminded however, that in 
these studies peritoneal macrophages, and not Kupffer cells were used. 
Seguin et al. found only minimal interaction of P. berghei sporozoites with murine 
Kupffer cells in vitro, in contrast to high phagocytic interaction of these cells with 
Leishmania major amastigotes21. They conclude that Kupffer cells play a minor role 
in resistance to infection with malaria sporozoites. Another explanation of these 
results could be that this poor interaction reflects in part the known relative 
resistance of Balb/cJ mice to infection with P. berghei sporozoites22. For this 
explanation, however, it is necessary to accept the Kupffer cell 'gate' theory. 
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VII. Is Kupffer cell passage essential for schizont development? 
Under normal conditions sporozoites are cleared from the liver sinusoids by 
actively or passively entering Kupffer cells Subsequently, they have to escape 
from these cells on the parenchymal side to reach the hepatocytes through the space 
of Disse One may wonder whether this Kupffer cell passage concerns only passing 
through a 'gate' or whether the Kupffer cell acts as a 'sieve' which destroys the 
less viable parasites Also, Kupffer cell passage may alter the sporozoite surface as 
a preparation for subsequent hepatocyte invasion and development into a mature 
schizont The following approaches have been employed to investigate possible 
specific functions of Kupffer cells in the development of liver schizonts 
VIII. Experimental Kupffer cell blockade and liver schizont development. 
Verhave et al studied the effect of silica treatment on the development of liver 
schizonts from Plasmodium berghei5 As has been mentioned previously, silica 
particles are internalized by phagocytes, which hereby become incapacitated They 
found that the number of schizonts developing in the liver, was significantly 
reduced in silica treated rats This finding was confirmed by Sinden and Smith, 
who also reported a decreased density of Kupffer cells in the livers of silica treated 
rats7 It was concluded that Kupffer cells are essential for establishment of 
infection The decreased number of schizonts was ascribed to the reduced capacity 
of Kupffer cells to 'catch' circulating sporozoites and locate them in the liver 
parenchyma As has been reported now, silica treatment induces high plasma levels 
ot interleukin-6, which is known to inhibit schizont development2324 
IX. Kupffer cell depletion and schizont development. 
In recent years, Van Rooijen developed a new method for selective elimination of 
macrophages, by allowing these cells to ingest hposome-encapsulated dichlorome-
thylene diphosphonate (Cl^MDP), high concentrations of the drug are released into 
the interior of the cells as soon as the liposomal phospholipid bilayers are disrupted 
by intracellular enzymes25 This treatment does not induce IL-6 release into the 
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circulation. Using this method, we depleted rat livers from Kupffer cells, prior to 
i.v. injection of P. berghei sporozoites and found that the number of developing 
schizonts increased significantly24. It was concluded that the mere presence of 
Kupffer cells is not necessary for clearance of sporozoites from the circulation. 
Moreover, these results suggest that sporozoites are actively involved in their 
invasion into the liver and are not just 'trapped' by Kupffer cells. If sporozoites are 
capable of rapidly penetrating macrophages in a 'needling' fashion, as reported by 
Vanderbergh et al., they might do the same with endothelial cells to enter the space 
of Disse19. This, however has never been observed. 
The increased number of liver schizonts in CL2MDP treated rats can be interpreted 
as resulting from reduced killing by Kupffer cells. It should be reminded however, 
that also spleen macrophages are depleted with this treatment. This 'temporary 
splenectomy' may on it self result in an increase of liver schizont density by 
allowing more sporozoites repeated passage through the liver sinusoids. 
X. Influence of serum factors on sporozoite penetration and schizont 
development. 
Before sporozoites are cleared from the circulation they are necessarily exposed to 
the blood for some time. This exposure could also have its influence on the fate of 
the parasites. Several approaches have been employed to study the effect of specific 
and non-specific serum factors. The majority of these studies has been performed 
in vitro, thus eliminating the effect of the reticulo-endothelial system. 
In the presence of monoclonal antibody against circumsporozoite protein (CSP), 
sporozoites were shown to be immobilized and phagocytosed by macrophages20. 
Similarly, it was shown in another study that opsonized P. berghei sporozoites 
were ingested and uniformly destroyed by murine Kupffer cells21. Ferreira et al. 
reported a dose dependent decrease in infectivity of Plasmodium berghei sporozoi-
tes of up to 99.7% , after pre-incubation with a monoclonal antibody26. Unfortuna-
tely, despite the very high efficiency of this antibody, all infected rats in this study 
developed parasitaemia after a prolonged delay. This reflects the very high succes 
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rate of the parasite after hepatocyte penetration. 
Pied et al. reported that the number of developing schizonts in rat hepatocytes 
could be reduced both in vivo and in vitro by pre-incubation of P. berghei 
sporozoites with acute phase serum or purified C-reactive protein27. Whether this 
was accomplished by inhibition of penetration in Kupffer cells or hepatocytes, or 
by enhanced intracellular destruction, was not specified. 
Cytokines, such as interferon gamma (IFN-7), tumor necrosis factor alpha (TNF-
a), interleukin (IL)-l and IL-6 were shown to interfere with sporozoite penetration 
and/or intra-hepatocytic maturation28"32. The inhibitory effect of IFN-γ is mediated 
through the induction of nitric oxide production by hepatocytes29. The inhibitory 
effect of TNF-a on liver schizont development could only be demonstrated when 
hepatocyte cultures also contained non-parenchymal liver cells (among which are 
Kupffer cells and lymphocytes), which are stimulated to produce IL-1 and IL-630. 
II-1 was shown to inhibit sporozoite penetration, but it also induces IL-6 producti­
on
31 32
. IL-6 stimulates hepatocytes to acute phase protein and nitric oxide synthe­
sis33·34. These substances directly inhibit schizont maturation. IL-6 also induces the 
production of reactive oxygen metabolites, which also have an inhibitory effect on 
schizont maturation35. 
X. The cellular response in the liver 
Inflammatory responses to Plasmodium hepatic schizonts within the livers of non-
immunized animals have long been assumed to occur only after the parasites have 
matured and have started to release merozoites. However, in 1987 a study by Meis 
et al. showed cellular infiltrations of rat Kupffer cells, monocytes, monocyte 
derived macrophages and neutrophils, surrounding and destroying about 30% of 
nearly mature P. berghei schizonts36. Recently, Khan et al reported that in older, 
but immunologically still naive rats, these infiltrations already started to appear 
before the release of merozoites into the circulation37. Older rats (8-10 weeks) 
developed more infiltrations than young rats (4 weeks). This corresponded with the 
lower number of developing schizonts that is observed in the former. In the same 
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study, schizont and infiltrate density were also shown to be inversely related in 
mice; infection with P. voeli sporozoites, to which Balb/c mice are highly 
sensitive, induced significantly less infiltrates than sporozoites of P. berghei , to 
which they are relatively resistant. 
Besides this rather late, schizont-oriented inflammatory response, Khan et al. 
reported a generalized cellular inflammation within the rat liver, that appeared at 
about 4 h after injection of viable P. berghei sporozoites38. In contrast to the late 
reaction however, developing schizonts did not appear to be the target of these 
early inflammatory cells. 
Hoffman et al. found a significant increase of cellullar infiltrations in livers of mice 
which were immunized with irradiated P. berghei sporozoites a few weeks before 
infection. In these mice the number of developing liver schizonts was significantly 
lower than in control mice. They demonstrated that the infiltrates, as well as the 
inhibition of schizont development were induced by malaria-specific CD8+ Τ cells. 
It would be of interest to know, whether in CSP-immunized animals, these cellular 
infiltrates also contain CSP-specific CD8+ Τ cells. 
XI. Conclusions 
Tissue macrophages play a key role in the clearance of malaria sporozoites from 
the circulation. There are conflicting opinions about whether sporozoite-Kupffer 
cell interaction mainly concerns active penetration or phagocytosis. It is clear 
however from recent in vitro and in vivo studies, that Kupffer cells are not 
essential for succesful penetration and maturation of sporozoites in hepatocytes. As 
it is the case in the spleen, probably the majority of sporozoites that are interna­
lised by macrophages in the liver, are destroyed. Still a number of sporozoites is 
able to escape from Kupffer cells and to penetrate the host cell in the liver 
parenchyma. Since the role of the Kupffer cell is defensive and permissive at the 
same time, it may be extremely difficult, if not impossible to block the cycle of the 
parasite at the level of clearance from the liver sinusoids. Several serum factors 
such as acute phase proteins, cytokines and especially anti-sporozoite antibodies 
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have been shown to reduce the number of developing liver schizonts. A 'second 
shot' is provided by the cellular response that is mounted a few hours before the 
liver schizonts start to liberate merozoites. However, none of these defense mecha­
nisms is sufficient to prevent parasitaemia, because a single escaped parasite is able 
to initiate the blood infection cycle. In the future, protection could possibly be 
provided by manipulation at the level of the hepatocyte receptor or by selective 
destruction of infected hepatocytes by CSP-specific CD4 + and/or CD8+ Τ cell 
clones40"43. 
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CHAPTER VI 
Dietary fish-oil supplementation inhibits Plasmodium berghei liver schizont 
development and reduces cytokine production capacity in rats 
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Abstract 
Experimental primary infection with Plasmodium berghei in rats has been shown to 
be influenced by several cytokines. Dietary fish oil supplementation has been 
shown to influence cytokine production capacity and to protect mice against 
cerebral malaria. We investigated the effect of dietary fish-oil supplementation on 
cytokine and nitric oxide production and on liver schizont development and 
parasitaemia in male Brown Norway rats. Control groups were fed either corn-oil 
diet (CO), or standard lab chow (LC). After six weeks on either diet, fish-oil (FO) 
fed rats had a significantly lower production of interleukin-1 and interleukin-6 after 
LPS stimulation and also significantly lower numbers of liver schizonts, compared 
to CO or LC fed animals. Upon direct inoculation of sporozoites by infected mos-
quitoes, FO rats developed parasitaemia at the same rate as CO rats. We conclude 
that in rats, fish-oil diet reduces the production capacity of interleukin-1 and 
interleukin-6 and inhibits schizont development after i.v. inoculation of P. berghei 
sporozoites, but does not protect against natural infection. Fish-oil diet does not 
influence nitric oxide production from peritoneal macrophages. 
77 
Introduction 
The development of liver schizonts of Plasmodium berghei in rodent hepatocytes is 
known to be influenced by cytokines. In vitro, interferon gamma, tumour necrosis 
factor alpha (TNF-a), interleukin-1 (IL-1) and interleukin-6 (IL-6) have been 
shown to inhibit both sporozoite penetration and schizont development [1-4]. This 
inhibition seems to be due to induction of a defensive response in hepatocytes, 
since pre-incubation of sporozoites with IL-6 has no influence on schizont 
development [4]. Recently, we demonstrated an inhibitory effect of in vivo 
administration of IL-1 and IL-6 in Brown Norway rats [5]. Also, induction of 
endogenous cytokine production by an inflammatory stimulus was shown to reduce 
schizont development. 
Dietary fish-oil supplementation has been shown to influence cytokine production in 
several species [6-10]. At the same time, it has been shown to exert a beneficial 
effect on the course of several inflammatory and infectious conditions, such as 
rheumatoid arthritis (in humans), Gram-negative sepsis and cerebral malaria (in 
mice) [10-12]. In humans the beneficial effect in rheumatoid arthritis seems to be 
accompanied by a reduced cytokine response to inflammatory conditions [12]. In 
mice however, a fish-oil enriched diet was shown to increase cytokine production 
capacity, but still protected the animals against cerebral malaria and Gram-negative 
sepsis [10,13]. We investigated whether fish oil supplementation had an influence 
on schizont development and parasitaemia in rats, and whether this influence was 
accompanied by changes in cytokine production capacity. Nussler et al demon-
strated the inducibility of nitric oxide (NO) by cytokines and also that NO strongly 
inhibits schizont development in vitro [14,15]. We therefore assessed the synthesis 
of NO in peritoneal cell culture supernatants from fish-oil supplemented and control 
rats. 
Materials and Methods 
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Rats 
Male Brown Norway (BN) rats were obtained from Harlan Olac Ltd., Shaw's 
Farm, Blackthorn, Bicester, 0X6 OTP, UK. Rats were housed under specific 
pathogen-free conditions in our central animal housing facilities. At the start of the 
diets, the rats were five weeks old. 
Diets 
Three groups of rats were fed a fat-free standard reference diet as a dry powder 
(Hope Farms, Woerden, The Netherlands), supplemented with a. (wt/wt) 14 % 
fish oil (EPAX 3000 TG, a kind gift from Pronova Biocare A.S., Sandefjord, 
Norway) and 1% corn oil (Mazóla, The Netherlands) (fish oil group, FO) b. 15% 
com oil (corn oil group, CO) and, only in experiment 2, с standard lab chow 
without supplementation (control group, LC). In these experiments, oil supplements 
represented about 28% of total calory intake. To overcome the para-aminobenzoic 
acid (PABA) deficiency of the standard reference diet, PABA was added to the 
acidified, ad libitum provided drinking water. 
Production of P. berghei infected mosquitoes 
Female Anopheles gambiae mosquitoes, which are routinely cultured in the 
insectary of our institute, were allowed to feed on Swiss mice, which had been 
inoculated three days earlier with P. berghei parasitized erythrocytes. The rate of 
mosquito infection was established by assessment of oocyst development in the 
midguts of a sample of mosquitoes one week after the bloodmeal. Two weeks later 
another sample of mosquitoes was dissected for assessment of the sporozoite rate, 
i.e. the percentage of mosquitoes in which sporozoites could be detected in the 
salivary glands. 
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Isolation of sporozoites 
Sporozoites of P.berghei (ANKA strain) were harvested from Anopheles gambiae 
mosquitoes, 21 days after infection and purified on a biphasic gradient containing 
urographin and fetal calf serum (FCS). Live sporozoites in 1 ml Medium 199 were 
injected into the tail vein. 
Evaluation of the number of schizonts 
44 hours after injection of sporozoites, rats were anaesthesized and killed by 
cervical dislocation and livers were removed. Sections of the left liver lobe were 
fixed in formaldehyde. Paraffine sections (7 μτη) were prepared and stained with 
hematoxylin and eosin. The number of liver schizonts (exo-erythrocytic forms or 
EEF) per cm2 liver section from each rat was assessed by light microscopy. 
In vitro stimulation of peritoneal macrophages 
After six weeks on either diet (FO, CO, LC) five rats per group were 
anaesthesized with ether. The peritoneal cavity of each rat was rinsed with 30 ml 
of sterile PBS, containing 5% FCS. The aspirate was centrifuged and resuspended 
in Iscove's modified Dulbecco's medium (IMDM), supplemented with 10% FCS, 
50 μΜ ß-ME (all Gibco, Grand Island, NY), 40 ¿¿g/ml gentamicin (Essex, 
Amstelveen, The Netherlands) and 8 U/ml rhIL-6. The proportion of macrophages 
in each suspension was assessed by peroxidase staining. From each cell suspension 
2 χ 0.5 ml was seeded in 24 well culture plates (Costar, Cambridge, MA) at a 
density of 10e6/ml. After overnight culture, supernatants were removed and fresh 
medium, with or without LPS (serotype 0111:B4, Sigma Chemicals, Brussels, 
Belgium) 10 ng/ml, was added to each well. The cells were incubated for another 
24 h and supernatants were stored at -20 °C, until measurement of cytokine and 
N02 levels. After aspiration of supernatants, fresh medium was added to the cells, 
which were then lysed by three cycles of freezing and thawing. This suspension 
was used for measurement of cell-associated IL-1. 
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IL-6 bioassay 
IL-6 was measured in plasma samples using the B9 bioassay [16]. Briefly, cells of 
the IL-6-dependent murine hybridoma cell line (B9) were grown at a density of 0.1 
-1 χ lOVml in IMDM, supplemented with the same ingredients as described above. 
Before the assay, B9 cells were harvested by centrifugation and washed twice with 
IL-6-free medium. B9 cells were seeded at 5000 cells/200 μΐ in flat bottom wells 
(Costar Europe, Badhoevedorp, The Netherlands) in the presence of plasma 
samples in appropriate dilutions. Proliferation was measured by a [3H]Thymidine 
pulse (Amersham Int.,Amersham,GB; 0.7-1.1 χ 10" MBq/mmol sp. act.) during 
the last 16 hours of a 96-hours culture period. Per well, 37 kBq was added. 
Samples were tested in triplicate and were related to a standard curve included in 
each experiment. One U/ml of IL-6 gives rise to half-maximal proliferation by 
definition. The sensitivity of the assay is 0.3 U/ml. 
Measurement of IL-1 
A cloned murine Τ cell line (D10.G4.1) was derived from primed AKR/J lymph 
node Τ cells [17]. A subline of these cells, (D10(N4)M), can be propagated in vitro 
in the presence of EL4-conditioned medium (see below). Cells were cultured in 
IMDM supplemented with 5% FCS, 5 χ IO"5 M 2-mercapto-ethanol, penicillin, 
streptomycin and 10% EL4-conditioned medium. For the assay, cells were harve­
sted by centrifugation, washed once and used at 104 cells/200 μ\ flat-bottom well in 
the presence of a suboptimal concentration (300 U/ml) of rhIL-2 (a kind gift from 
Hoffman-La Roche, Nutley, NJ, USA). Cells were labeled with 37 kBq [3H]Thy-
midine during the last 4 h of a 72 h culture period [18]. This assay measures IL-la 
and IL-lß. rhIL-lß (a kind gift of Hoffman- La Roche, Nutley, NJ, USA) was 
used as a standard. The sensitivity of the assy is 1 pg/ml. All cultures were 
performed in triplicate and the standard deviation was always < 10%. 
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EL4-conditioned medium 
EL4 cells (a murine thymoma derived cell-line) were grown in IMDM 
supplemented with 5% FCS, 5 χ IO"5 M 2-mercapto-ethanol, penicillin and 
streptomycin. To prepare conditioned medium, EL4 cells were harvested by 
centrifugation and incubated at 106 cells/ml in large culture flasks in the same 
medium, together with 10 Mg/ml concanavalin A (ConA) and 10 ng/ml phorbol 
my ristate acetate (PMA). After 18 h the supernatant was harvested and stored at -
20 °C until use. 
Measurement of nitric oxide 
Nitric oxide synthesis, as reflected by N02 levels in culture supematants, was 
assessed by the Griess reaction [19,20]. Briefly, 100 μ\ aliquots of supematants 
were plated in 96 well microliter plates. An equal volume of Griess reagent 
(naphtylene-diamine-dihydrochloride 0.1%, phosphoric acid 2.5% and sulfanyla-
mide 1%, dissolved in demineralised water) was added to each well. After 10 
minutes of incubation at room temperature, optical density was measured in an 
ELISA reader at 540 nm. Samples were tested in triplicate and related to a 
standard curve included in each experiment. 
Statistical analysis 
All data were analysed using Wilcoxon's Τ test. 
Results 
Influence of fish-oil diet on body-, liver- and spleen-weight 
In the first experiment, body-, spleen- and liver-weights were assessed in rats 
which were used for isolation of peritoneal macrophages. Although all mean 
weights were lower in CO rats, none of them differed statistically significant from 
FO rats (p-values 0.31, 0.56 and 0.15 respectively). 
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Inhibition of schizont development by fish oil supplementation 
In the first experiment, only FO and CO groups were included After six weeks of 
diet the rats were injected with 5 χ IO5 sporozoites intravenously Fish-oil fed rats 
developed significantly lower numbers of EEF per cm2 liver section than rats on 
corn-oil diet (Table 1) These results do not exclude the possibility that the corn-oil 
supplemented diet enhanced the development of EEF Therefore the experiment 
was repeated with the addition of a control group, which was fed standard lab 
chow and PABA supplemented drinking water In this experiment, the rats were 
injected with 4 χ IO5 sporozoites EEF numbers in the control group and in the 
corn-oil group did not differ significantly, but in this experiment the rats on fish-oil 
diet had again significantly lower EEF densities (Table 1) 
Table 1 Influence of diet on schizont development 
Exp 
I 
II 
η 
5 
5 
sporozoites 
5 χ 105 
4 x 105 
number of schizonts 
CO 
35 5 ± 4 2 
22 5 ± 3 0 
FO 
6 3 ± 6 
4 4 + 2 2 
per cm2 
LC 
ND 
21 5 ± 8 
After six weeks on CO, FO or LC diet, rats were injected ι ν with Ρ berghei sporozoites After 44 
h schizont density was assessed m resected livers In both experiments FO diet significantly 
reduced schizont density (Wilcoxon, ρ < 0 05) CO diet had no influence on schizont 
development ND = not done 
Influence of fish-oil diet on prepatent period and parasitaemia 
Since fish-oil diet strongly reduced schizont development, we tentatively concluded 
that the diet should also have an effect on the pre-patent period (the time-lapse 
between inoculation of sporozoites and appearance of erythrocytic forms in the 
circulation, assessed by blood smears) and on the level of parasitaemia Two 
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groups of six fish-oil or corn-oil fed rats were exposed individually for 10 min to 
about 25 P. berghei infected A. gambiae mosquitoes from the same batch, with a 
pre-assessed sporozoite rate of 75%. After feeding, we counted the number of 
mosquitoes who were engorged with blood. In every cage, at least 23 mosquitoes 
were fully fed. From 72 h after the bloodmeal until day 11, thick smears and blood 
slides from each rat were prepared daily for assessment of prepatent period and 
parasitaemia. On day six, parasitized erythrocytes were detected for the first time 
in all CO and FO rats. Parasitaemia was < 0 1 % in all rats, except for one CO 
rat with 0 3% parasitized erythrocytes. On the following days parasitaemia 
increased gradually in both groups, peaked on day nine and then rapidly declined. 
There was no statistically significant difference in parasitaemia between rats from 
the two groups. The results are depicted in figure 1. 
Figure 1. Influence of fish-oil diet on 
parasitaemia 
Parasites/1000 erythrocytes 
3 5 6 7 6 9 11 
Days after infection 
"~*~~ Corn-oil —B~ Fish-oil 
After six weeks on Fish-oil (FO) or Corn-oil (CO) diet, batches of about 25 infected mosquitoes 
per rat were allowed to feed Each group consisted of 6 rats From day 3 onwards bloodslides 
were prepared and read daily for assessment of parasitaemia Results are presented as mean 
parasitaemia ± SD There was no statistically significant difference in parasitaemia between the 
groups at any of the measured points (Wilcoxon) 
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Influence of fish-oil diet on cytokine production capacity of peritoneal 
macrophages 
Billiar et al. demonstrated that in rats, fish-oil diet reduces the cytokine production 
capacity of liver macrophages [7]. This reduction seemed contradictory to our 
findings that IL-6 and/or IL-1 administration, as well as dietary fish-oil sup­
plementation inhibit liver schizont development. Therefore, we investigated the 
effect of fish-oil diet on the cytokine production capacity of peritoneal macrophages 
in vitro. Peritoneal macrophages were preferred to liver macrophages, because the 
former can be obtained with minimal manipulation of the cells. The proportion of 
macrophages in each suspension, assessed by peroxidase staining, was always 
between 75 and 85 %. 
Cell-associated and secreted IL-1 were measured separately, because IL-1 α is 
hardly secreted in the supernatant [21]. Concentrations of bio-active IL-1 in 
supernatants of LPS stimulated macrophages were significantly lower in FO- than 
in CO- or LC-rats (p < 0.05). Concentrations of cell associated IL-1 were also 
lower in FO rats, but the difference was not statistically significant (p = 0.06) 
(Fig. 2). Similar results were obtained for IL-6 levels, wich were significantly 
lower in supernatants from FO rats (Fig. 3). 
Influence of fish-oil diet on LPS stimulated NO synthesis by macrophages 
It has been demonstrated that nitric oxide (NO) strongly inhibits schizont 
development in hepatocyte cultures [14]. NO synthesis can be induced in several 
cell types such as endothelial cells, hepatocytes and macrophages [15,22,23]. 
Dietary fish-oil supplementation has been shown to augment NO synthesis in endo­
thelial cells [24]. In order to investigate whether increased inducibility of NO 
production in macrophages of fish-oil supplemented rats could explain the reduced 
schizont development in this group, N0 2 levels were measured in culture superna­
tants of peritoneal macrophages with and without LPS stimulation. Co-culture with 
LPS induced a statistically significant increase of about 20%. However, there was 
no difference in N02 levels between the three dietary groups (table 2). 
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-LPS 
•LPS 
Figure 2. Fish-oil diet reduces IL-1 
production capacity of macrophages. 
IL-1 (ng/ml) 
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a. cell associated 
IL-1 (ng/ml) 
-LPS 
•LPS 
b secreted 
^ • : ' : l " j . 
FO 
Peritoneal macrophages from FO, CO and LC rats were cultured for 24 h with or without LPS 
IL-1 levels were measured in supernatants (a) and in suspensions of lysed cells (b) with a bioassay 
using DIO cells In stimulated cultures, IL-1 levels in the supernatants were significantly higher 
for CO and LC compared to FO (p < 0 05) A similar difference was found for cell associated IL-
1 (p =0 06) 
б 
Figure 3. Fish-oil diet reduces IL-6 
production capacity of macrophages. 
-LPS 
•LPS 
1000 
8 0 0 
6 0 0 
4 0 0 
2 0 0 
IL6 (U/ml) 
Peritoneal macrophages from FO, CO and LC rats were cultured for 24 h with or without LPS 
IL-1 levels were measured in supernatants (a) and in suspensions of lysed cells φ) with a bioassay 
using DIO cells In stimulated cultures, IL-1 levels in the supernatants were significantly higher 
for CO and LC compared to FO (p < 0 05) A similar difference was found for cell associated IL-
1 φ =0 06) 
Table 2. N02 levels in supernatants of peritoneal macrophages 
-LPS + LPS 7o increase 
LC 59.0 ± 4.54 71.5 ± 12.29 21.4 ±12.2 .03 
CO 41.1 ±11.89 47.8 ± 12.96 17.2 ± 11.6 .03 
FO 49.5 ± 9.47 59.7 ± 11.67 21.8 ± 20.5 .03 
Peritoneal macrophages were harvested from five rats from each group and were cultured separa­
tely with or without LPS 10 ng/ml Mean concentrations + SEM are expressed as mmol/ml In all 
groups the N02 concentration was significantly higher in LPS stimulated samples ( p-values 
presented in fifth column). 
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Discussion 
Our results show, that a fish-oil supplemented diet can strongly reduce schizont 
development upon i.v. administration of P. berghei sporozoites in rats. These 
findings suggest a protective effect of fish-oil on primary malaria infection in rats. 
However, after infection by mosquito bites, fish-oil fed rats developed parasitaemia 
at the same time and rate as control rats. One may expect that the number of liver 
schizonts is directly related to the rate at which infected animals develop 
parasitaemia. An explanation of these results might be, that multiplication of 
merozoites, once they have been liberated in the blood circulation, is enhanced by 
fish-oil supplementation. Curfs et al demonstrated that exogenous IL-1 could reduce 
parasitaemia in mice infected with P. berghei [25]). Since FO rats have a conside-
rably lower IL-1 production capacity than control rats, this may have contributed to 
the erythrocytic development of relatively more merozoites. Also, Schmidt et al. 
demonstrated that in monkeys injected with either IO4 or 107 sporozoites, there was 
no statistically significant difference between prepatent periods in the two groups 
[26]. Therefore, the six-fold reduction in liver schizont density by FO diet may not 
be enough to observe differences in prepatent period or in the level of 
parasitaemia. 
In this study we also demonstrate the reduced cytokine production capacity of 
peritoneal macrophages from fish-oil supplemented rats. These results coroborate 
the findings of Billiar et al., who showed reduced IL-1 production by liver 
macrophages from fish-oil fed rats [7]. The difference between cell-associated and 
secreted IL-1 in our study, suggests that production of IL-1 ß is much stronger 
reduced [21]. This is in agreement with the results of Endres et al. and Meydani et 
al. (6,27). In their experiments in humans, fish-oil diet significantly reduced the ex 
vivo production of TNF, IL-Iß and IL-6 by stimulated peripheral blood mononu-
clear cells. In mice however, Blok et al. found that protection against cerebral 
malaria was associated with increased cytokine production capacity of peritoneal 
macrophages [10]. This underlines once more, that extrapolation of experimental 
results in an animal model to humans or other species, can lead one astray. 
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In several in vitro experiments and also in our own previous in vivo study, it was 
demonstrated that exogenous IL-1 and IL-6 both inhibit schizont development [3,5]. 
We also showed that treatment with turpentine oil, which causes endogenous IL-6 
production, significantly reduces schizont development. Finally, the effect of 
exogenous IL-1 could be reversed by treatment with anti-IL6 antibody. Thus, 
inhibition of schizont development seems to be accomplished by IL-6. In this study 
however, fish-oil diet inhibits schizont development and at the same time reduces 
cytokine production capacity. This discrepancy urged us to look for an alternative 
mechanism, by which dietary fish-oil supplementation might inhibit schizont 
development. Recently, Nüssler et al. demonstrated the inhibitory effect of nitric 
oxide on schizonts in vitro [14,15]. We found that N02 concentrations in macrop-
hage culture supernatants from fish-oil fed rats were not elevated, compared to CO 
or LC rats. It is concluded that the inhibition of schizont development, accom-
plished by fish-oil diet, is not mediated through cytokines or nitric oxide, but 
through another yet unexplained mechanism and that this mechanism is able to 
make up for the reduced cytokine production. 
The effects of dietary polyunsaturated fatty acids on cells, mainly concern 
membrane structure and function, enzyme production and receptor expression on 
the cell surface [28]. Expression of several membrane receptors is known to be 
down-regulated by fish-oil diet [28-30]. Van Pelt et al identified two membrane 
proteins in human hepatocytes, which are involved in the penetration of sporozoites 
[31]. Possibly, parallel to other cell surface receptors, sporozoite-specific receptors 
on the hepatocyte surface may also be downregulated by fish-oil diet, thus leading 
to a reduced penetration. Finally, it is known that fish-oil supplementation in mice 
also reduces prostaglandin E2 (PGE2) and leukotriene (LT) B4 synthesis, while 
PGE3 and LTB5 production is induced [32,33]. These changes may have an 
inhibitory effect on schizont development. 
In conclusion, this study demonstrates the significant but incomplete inhibitory 
effect of fish-oil diet on the development of liver schizonts. Furthermore, we 
confirmed the reduced cytokine production capacity of macrophages from fish-oil 
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fed rats and also found that fish-oil does not influence NO production of peritoneal 
macrophages. 
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CHAPTER VII 
SUMMARY AND GENERAL DISCUSSION 
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Criminals who intend to become sophisticated in their trade, can learn a lot from 
parasitology; it may not help them to avoid condemnation, but a prudent judge would 
have to admit, that the evidence of guilt is although very obvious, not absolutely sure. 
Unlike other microbes, parasites -especially protozoans- tend to undergo several meta-
morphoses and to follow obscure pathways in the course of their development, which 
makes it difficult to trace their whereabouts and their contribution to disease. Several 
decades of thorough research have disclosed this masquerade of many parasites, but still 
there remain parts in their life cycle which are not completely understood. 
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The aim of the studies presented in this thesis has been to investigate the role of 
non-specific defence mechanisms in primary malaria infection in a rodent model. 
In this model, we observed the influence of several interventions on the number of 
liver schizonts (Exo-erythrocytic forms or EEF) that develop after i.v. injection of 
P. berghei sporozoites. First we have shown that subcutaneous injection of 
turpentine oil significantly inhibits the development of EEF. Turpentine oil is 
known to induce general inflammation with systemic release of cytokines and acute 
phase proteins. In the same study we demonstrated the inhibitory effect of exoge­
nous interleukin (IL)-l and IL-6 on EEF development. The effect of IL-1 could be 
partially reversed by the administration of anti-IL-6 antibodies, demonstrating that 
IL-1 mainly exerts its effect via IL-6. The effect of cytokines on the development 
of liver schizonts in vitro has been established previously (1-3). The mechanism of 
action of several cytokines has been studied both in vivo and in vitro. Interferon-γ 
was the first cytokine shown to influence the development of EEF (1). Besides its 
ability to induce the production of other cytokines by monocytes and macrophages, 
Interferon-7 also has an inhibitory effect which is mediated through nitric oxide 
synthesis of hepatocytes (4). The addition of Tumor Necrosis Factor (TNF) to puri­
fied hepatocyte cultures was shown to have no effect on schizont development (2). 
When non-parenchymal cells (macrophages, monocytes and lymphocytes) were 
present in the cultures, TNF addition inhibited schizont maturation in a dose 
dependent manner. This indicates that TNF exerts its effect primarily through other 
cytokines (IL-1, IL-6). IL-1 exerts its effect in at least three different ways. First, 
it has been shown to inhibit sporozoite penetration into hepatocytes by an unknown 
mechanism (3). Secondly, it induces the production of acute phase proteins by 
hepatocytes (5). The third way is by induction of IL-6 production by monocytes 
and macrophages. The importance of this mechanism has been demonstrated here, 
by the neutralizing effect of anti-IL-6 antibodies (Chapter 1). 
Pied et al. demonstrated that IL-6 has no direct influence on the sporozoites, but on 
hepatocytes (6). IL-6 was shown to stimulate these cells to liberation of reactive 
oxygen intermediates, which inhibit schizont maturation. In another study it was 
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shown that C-reactive protein (CRP) also inhibits EEF development in vivo and in 
vitro (5). Because in contrast to a2-Macroglobulin, CRP is not a major acute phase 
protein in rats, we investigated whether the first also inhibited EEF development in 
vivo (7). As demonstrated in chapter IV, this was indeed the case. 
In 1985 Meis and Verhave reported that Brown Norway (BN) rats were much more 
susceptible to infection with P. berghei sporozoites than Sprague Dawley (SD) rats 
(8). Because this was observed in immunologically naive rats, we investigated 
whether the two rat strains also differed in their capacity to produce cytokines and 
acute phase proteins. In chapter IV we demonstrate, that peritoneal and splenic 
macrophages from SD rats have a significantly higher production capacity of IL-6 
upon LPS stimulation in vitro. Also, IL-6 stimulated hepatocytes from these rats 
produce more a2-Macroglobulin in vitro, compared to BN rats. These findings are 
in concert with the notion that inflammatory mediators have a role in the outcome 
of experimental sporozoite induced malaria infections. 
An interesting aspect of the host-parasite interaction is the role of macrophages in 
the homing process of sporozoites in hepatocytes. Although many investigators 
have paid attention to this point and have demonstrated several aspects of interacti-
on, there is still no definitive conclusion whether the way for sporozoites to leave 
the bloodstream and enter hepatocytes, is passage through Kupffer cells. We have 
depleted rats from macrophages by treatment with liposomal dichloromethylene 
diphophonate (CLjMDP) before the inoculation of live sporozoites. Macrophage-
depleted rats developed about five times more EEF than control rats (Chapter III). 
These experiments showed clearly, that sporozoites do not need the presence of 
Kupffer cells for succesful penetration of hepatocytes and subsequent development 
into liver schizonts, which has already been demonstrated in vitro (9). The fact that 
EEF density was fivefold increased suggested that the majority of ingested 
sporozoites is destroyed during passage through the Kupffer cell, demonstrating a 
protective, rather than a facilitating role for Kupffer cells in primary malaria 
infection. This protection may be implemented by destruction after internalization 
or by inhibition of intrahepatocytic development by production of cytokines. Our 
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study did not answer the question whether treatment with liposomal C12MDP causes 
gaps in the sinusoidal lining, or whether after elimination of the Kupffer cells, the 
vacancies are immediately occupied by endothelial cells. In the former case sporo-
zoites may enter the liver parenchyma directly; in the latter, endothelial cells -in 
the absence of Kupffer cells- may have differentiated into phagocytes with a lower 
lysozymal capacity than Kupffer cells (10). Electron microscopic studies of Kupffer 
cell depleted livers should provide an answer to this question. 
Another approach to clarify the role of Kupffer cells, is inactivation of their 
phagocytic capacity. This approach has been carried out by Verhave et al. and also 
by Sinden and Smith (11,12). They used Silica particles, that are internalized by 
macrophages, which thereby become incapacitated. Both groups found, that silica 
treatment significantly inhibited EEF development. As has been demonstrated in 
chapter III however, silica treatment induces production and release of IL-6, that 
certainly has an inhibitory effect on EEF development (13). 
Gadoliniumchloride (GdCl3), the salt of a rare earth metal, has also been shown to 
block phagocytosis of phagocytic cells (14, 15). Recently we found that this 
substance does not induce systemic release of (measurable levels of) IL-6. This 
does not preclude increased local production and secretion in the liver parenchyma, 
although Callery et al. report reduced IL-1 production capacity of Kupffer cells in 
vitro, after treatment with GdCl3 (15). Administration of GdCl3 to rats on two 
consecutive days prior to inoculation of sporozoites, resulted in significantly lower 
numbers of developing EEF compared to control animals (Table 1). GdCl3 had no 
effect on sporozoite infectivity and was not hepatotoxic, as indicated by serum 
transaminase levels (data not shown). This of course does not exclude the induction 
of other as yet unknown effects on hepatocytes, which may impair their suitability 
as a host cell. 
Treatment with liposome-encapsulated C12MDP does not only deplete rat livers 
from Kupffer cells; also spleen macrophages are destroyed (16). The question 
arises whether the effects observed in our studies was at least in part due to 
depletion of spleen macrophages. Therefore it was necessary to consider the role of 
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Table 1. Influence of gadoliniumchloride treatment on EEF development 
Exp 
I 
II 
number of 
sporozoites 
1 χ 10s 
1 χ 105 
EEF density 
GDCI3 
17.4 ± 11.4 
12.2 ± 5.2 
PBS 
37.2 ± 10.6 
36.2 ± 10.6 
Ρ 
< 0.05 
< 0.05 
In two separate experiments five male Wistar rats were injected ι ν on two consecutive days with 
GDCl¡, 7 mg/kg in normal saline Control groups received only salme On the third day al rats 
were injected ι ν with Ρ berghei sporozoites EEF density is expressed as the number of liver 
schizonts per square centimeter 
the spleen in sporozoite induced experimental malaria infections. Ferreira et al. 
reported that splenectomy prior to sporozoite inoculation significantly increased the 
amount of parasite DNA in the liver at 44 h (17). They also demonstrated that at 5 
h post sporozoite inoculation, there is a high concentration of parasite DNA in the 
spleen. This suggested that the spleen clears a considerable number of sporozoites 
from the circulation. In 1980, Verhave et al. reported their results on splenectomy 
prior to sporozoite inoculation (11). They found no alteration by splenectomy. The 
difference with Ferreira's study was, besides the counting method (histology versus 
a DNA probe) that Verhave employed a recovery period for the splenectomized 
and sham-operated rats of only two days versus Ferreira's ten days. We 
hypothesized that because of the rather short recovery period in Verhave's experi­
ments, surgery-induced cytokinaemia and acute phase protein production in both 
groups might have obscured the differences. Therefore we repeated the experiment: 
splenectomized and sham-operated rats were infected with sporozoites of P. berghei 
after a recovery period of 14 days. We found no statistically significant difference 
in EEF density between the two groups (Table 2). It was concluded that in our 
experimental model, the spleen has no important role in the clearance of viable 
sporozoites from the circulation, leaving a central role for the Kupffer cell. 
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Table 2. Splenectony has no effect on liver schizont development. 
number of EEF density 
Exp sporozoites Sham-operated Splenectomized ρ 
I 0 .4xl0 5 11.0 ± 2 . 2 10.4 + 3.4 ns 
II 1.5 χ 105 66.8 + 10.1 58.8 ± 15 ns 
In two separate experiments, male Wistar rats, five per group, were splenectomized or sham-
operated After a recovery period of 12 days, both groups received Ρ berehei sporozoites ι ν Schi-
zonts were counted in paraffine liver sections EEF density is expressed as the number of liver 
schizonts per square centimeter ns=not significant 
In chapter V we report the effect of dietary fish-oil supplementation on schizont 
development and on cytokine production capacity. Fish-oil diet induced a 
significant reduction of EEF development. At the same time, the cytokine 
production capacity of macrophages from these rats was also significantly lower, 
when compared to control rats. These results seem at variance with the correlation 
between susceptibility to sporozoite infection and cytokine production capacity, 
which we demonstrated in chapter IV. The mechanism that is implied in the inhibi­
tion of schizont development by dietary fish-oil supplementation remains elusive. 
The influence of fish-oil diet on nitric oxide synthesis by hepatocytes and on the 
production of acute phase proteins and reactive oxygen intermediates, has not been 
investigated, but since these mediators are all (but possibly not only) induced by 
cytokines, it is unlikely that this effort will provide a plausible explanation. The 
existence of sporozoite receptors on the hepatocyte plasma membrane has been 
postulated by Van Pelt et al. (18). Recently these receptors, and also the 
corresponding ligand on the sporozoite surface have been demonstrated by Cerami 
et al (19). From other studies it is known, that cell receptors can be down-
regulated by dietary fish-oil supplementation (20-22). It needs further investigation 
to determine whether the sporozoite receptors on the hepatocyte plasma membrane 
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are also implied in this down-regulation. Another possibility is that fish-oil diet 
induces metabolic changes in the hepatocytes, which makes them less suitable for 
schizont development. 
In one of the studies presented in this thesis, we investigated whether a different or 
altered susceptibility to P. berphei sporozoite infection, assessed on account of EEF 
development, was also reflected by the duration of prepatent period and the level of 
parasitaemia (Chapter VI). In this experiment, the rats were infected by mosquito 
bite, in order to mimic a natural situation. We found that fish-oil supplemented and 
control rats displayed no difference at this level. These findings raise some concern 
on the relevance of the number of EEF as endpoint in our studies. We know of 
course, that a single sporozoite that succeeds to develop into a mature liver 
schizont, releasing thousands of merozoites into the circulation, is enough to 
establish a malaria infection. It is also known that the size of the inoculum of 
sporozoites correlates poorly with duration of the pre-patent period (23). But, as 
has been demonstrated by Marsh et al. reduction of the number of infective bites 
(and thus of the sporozoite load) significantly reduces morbidity and mortality, 
especially in children, without necesarily reducing the prevalence of positive 
bloodslides in the population (24). In addition, it is important to know the actual 
contribution of non-specific immune modulators to inhibition of schizont develop-
ment: Noessler et al. demonstrated recently that the complete protection achieved 
by immunization with irradiated sporozoites is conveyed by non-specific induction 
of interferon-7 production of hepatocytes, rather than by specifically induced 
immunity against sporozoites or liver schizonts (25). 
The studies presented in this thesis support the current opinion that several 
inflammatory mediators have an inhibitory effect on the development of liver 
schizonts. Through a cascade of induced cytokine-production that can be initiated at 
any level, the direct inhibitors of liver schizont development, such as acute phase 
proteins, reactive oxygen intermediates and nitric oxide, come into action. 
An important question is, if and how this non-specific inhibition can be related to 
inhibition achieved by immunization. Immunization of mice and humans with 
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irradiated sporozoites has been shown to protect them against infection with viable 
sporozoites (26-29) This protection seems to be achieved by several mechanisms 
Passive transfer of anti-circumsporozoite mAbs was shown to protect mice against 
infection with Ρ berghei sporozoite (30) Tsuji et al demonstrated complete 
protection in Balb\c mice by a CD4+ cytolytic Τ cell clone, induced by immuni­
zation with irradiated sporozoites (31) This Τ cell clone, which produces 
mterferon-γ and IL-2 in vitro, recognizes a bloodstage antigen that is not present 
on the circumsporozoite Possibly it is only expressed after hepatocyte penetration 
Hoffman et al showed that infection of Balb\c mice, immunized with irradiated P_ 
berghei sporozoites, induces large numbers of infiltrates in the liver, in which 
CD8+ CTL were involved (32) These infiltrates were shown to destroy the 
majority of developing EEF The development of these infiltrates could also be 
induced by passive transfer of CD4 but not CD8 immune spleen cells 
Unfortunately, it was not reported whether these CD8+ CTL could prevent parasi-
taemia Recently, Nussler et al found that the protection induced by immunization 
with irradiated sporozoites was not species-specific, but merely due to induction of 
nitric oxide production of hepatocytes via mterferon-γ (25) They could completely 
protect Balb\c mice against Ρ berghei infection by immunization with irradiated P_ 
yoeln sporozoites Protection could be reversed by competitive inhibition of nitric 
oxide synthesis Finally, Migliorini et al reported protective antibody-mediated 
immunity against Ρ berghei sporozoites in up to 66% of Balb\c mice, achieved by 
immunization with either of two new synthetic (non-repeat) CS peptides that exhibit 
Τ cell helper activity, coupled to two CS repeats (B epitope) (33) One of these 
peptides could induce a similar degree of Τ cell mediated protection, when 
administered without the В epitope This demonstrates that in the same strain a 
double mechanism of protection can be obtained by a synthetic vaccine Dependent 
on the antigen used for immunization, protection was achieved by high serum anti-
repeat ab titers or by effector Τ cells 
It is extremely difficult, if not impossible to fit all these sometimes rather 
conflicting reports in one theory If Ρ yoeln sporozoites are able to induce a 
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CD4+ cytolytic Τ cell clone that recognizes developing schizonts of P. berphei. 
Tsuji and Nussler may demonstrate two sides of the same phenomenon, namely the 
destruction of developing schizonts through interferon-γ produced by a CD4+ Τ 
cell clone. This however does not explain the effect of (passively transferable) 
humoral protection, demonstrated by Potocnjac and by Migliorini (30,33). Genetic 
restriction is clearly implied in the differences between the mechanisms of 
protection between the used animal models (34). 
The importance of liver infiltrates for protection against parasitaemia has not been 
established; they have been reported previously in P. berghei infected Balb\c mice 
by Khan et al.(35). In these studies however, they were reported in immunolo­
gically naive animals and related to the host's susceptibility to the parasite. 
Inflammatory infiltrates, specific or non-specific as well as the afore-mentioned 
mediators don't have a complete blocking potential. Since specific Τ cell subsets 
seem to exert their final effect through these mechanisms, they may also be unable 
to provide complete protection. Also, as in mice, genetic restriction may be 
implied in humans. Therefore, in the end, large scale immunological protection 
against malaria may not be achieved by adressing only one stage of the parasite, 
but by a vaccine composed of antigens from different developmental phases. 
This chapter is intended to be an epilog, where the observations presented in the 
previous ones are related to each other and discussed in the perspective of blockade 
of the malaria cycle at the EEF level. It illustrates a well-known observation in 
science, and that is: the more we discover, the more we realize how little we are 
able to understand. 
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NEDERLANDSE SAMENVATTING 
108 
Dit proefschrift handelt over malaria-onderzoek dat werd uitgevoerd in een 
proefdiermodel. Hierbij werden ratten geïnfecteerd met een parasietensoort, waar 
alleen knaagdieren gevoelig voor zijn (Plasmodium berghei). Het model wordt 
gebruikt om inzicht te krijgen in het beloop van de infectie en in de wijze waarop 
dit kan worden beïnvloed. De zo verkregen kennis kan getoetst worden aan het 
beloop bij de mens en kan mogelijk als leidraad dienen voor het ontwikkelen van 
een vaccin. De centrale vraagstelling is in hoeverre ontstekingsmediatoren in de 
gastheer een rol spelen bij de ontwikkeling van de parasiet. In het eerste experi-
ment hebben wij door middel van onderhuidse toediening van terpentine de 
aanmaak van deze mediatoren gestimuleerd. Het bleek dat met terpentine 
behandelde ratten significant minder lever-parasieten ontwikkelden dan 
onbehandelde ratten. Vervolgens hebben wij onderzocht welke 
ontstekingsmediatoren voor dit effect verantwoordelijk waren. Zowel de cytokinen 
IL-1 en IL-6, als enkele acute fase eiwitten bleken een remmend effect op de 
ontwikkeling van leverparasieten te hebben. 
Brown Norway (BN) ratten zijn veel gevoeliger voor de malaria infectie dan 
Sprague Dawley (SD) ratten. Wij vroegen ons af of het verschil in gevoeligheid 
veroorzaakt werd door een verschil in de hoeveelheid cytokinen en acute fase 
eiwitten die deze ratten kunnen produceren. Van beide rattenstammen werden er 
cellen uit de buikholte en uit de lever geoogst en vervolgens werden deze cellen 
maximaal gestimuleerd om bovengenoemde stoffen te produceren. Het bleek dat de 
productie van SD ratten inderdaad veel hoger was dan die van BN ratten. Dit is 
compatibel met het verschil in gevoeligheid. 
Om zich in de lever te kunnen ontwikkelen moeten sporozoieten door de 
Kupffercellen heen. Deze cellen die in de wand van de bloedvaten van de lever 
zitten, hebben echter de functie om alle micro-organismen waar ze mee in contact 
komen te vernietigen. Wij onderzochten of ze deze functie ook ten opzichte van 
malaria parasieten vervulden en of de parasieten zónder deze cellen ook in staat 
waren om zich in de lever te ontwikkelen. Er werd een experiment uitgevoerd 
waarbij de Kupffercellen werden uitgeschakeld. Hierbij bleken de parasieten zich 
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juist veel beter te kunnen ontwikkelen. Onze conclusie was, dat de Kupffer cellen 
doorgaans de meeste parasieten vernietigen, maar dat steeds een aantal parasieten 
in staat is aan deze vernietiging te ontkomen, om zich vervolgens in de lever 
verder te ontwikkelen. 
Het gebruik van een dieet dat rijk is aan visolie blijkt bij diverse proefdieren, maar 
ook bij de mens het beloop van diverse infecties en andere ziekten gunstig te beïn-
vloeden. Wij onderzochten of dit ook het geval was voor malaria in de rat. Een 
groep ratten kreeg gedurende zes weken een visolie-rijk dieet, terwijl een andere 
groep een mais-olie dieet kreeg. Beide groepen werden vervolgens met malaria 
parasieten geïnfecteerd. Het bleek dat de visolie-groep veel minder leverparasieten 
ontwikkelde dan de maisolie-groep. De vraag rees toen of dit kwam doordat de 
visolie groep meer cytokinen produceerde dan de maisolie groep. Dat bleek juist 
andersom te zijn: door het visolie dieet gingen de ratten juist veel minder cytokinen 
produceren. Dit geeft aan dat het effect van visolie op een geheel andere wijze 
totstand komt. Het werkelijke mechanisme konden we niet achterhalen. 
Uit bovenstaande experimenten blijkt dat ontstekingsmediatoren weliswaar een 
remmende invloed hebben op de ontwikkeling van malaria parasieten in de lever, 
maar dat ze de infectie niet volledig blokkeren. Uit onderzoek in Gambia is geble-
ken dat met name bij kinderen, het ziektebeloop en de overleving gunstig worden 
beïnvloed door vermindering van het aantal parasieten per infectie. Om ziekte 
helemaal te voorkomen moet echter ook de laatste leverparasiet worden vernietigd. 
Het is duidelijk dat voor de preventie van malaria, inductie van de afweer tegen 
leverparasieten alleen onvoldoende is. Ook tegen andere stadia van de parasitaire 
cyclus zal een adequate afweer moeten worden geïnduceerd. 
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Stellingen 
BIJ HET PROEFSCHRIFT "INFLAMMATORY MEDIATORS IN THE DEVELOPMENT OF 
LIVER SCHIZONTS OF THE RODENT MALARIA PARASITE PLASMODIUM BERGHEI". 
De cytokinen IL-1 en IL-6 hebben in het ratte-model een remmend effect op de ont-
wikkeling van Plasmodium berghei leverschizonten. Het remmende effect van IL-1 
wordt teweeggebracht via IL-6. 
Het totstandkomen van een malaria-infectie door een infectieuze muggebeet, wordt 
bepaald door het vermogen van sporozoieten om na fagocytose door Kupffercellen, 
deze cellen nog voordat de lysosomale digestie is aangevangen, aan parenchymale 
zijde te verlaten. 
Het genetisch bepaalde, kwantitatieve verschil in acute fase respons tussen Brown 
Norway en Sprague Dawley ratten is waarschijnlijk mede verantwoordelijk voor het 
kwantitatieve verschil in de ontwikkeling van leverschizonten tussen deze rattenstam-
men. 
In de bevinding dat vis-olie dieet in het ratte-model de produktie van pro-inflamma-
toire cytokinen reduceert en tevens een remmende invloed heeft op de ontwikkeling 
van Plasmodium berghei leverschizonten, schuilt een schijnbare tegenstelling. 
Daar men met een transmissie-blokkerend vaccin het ontstaan van premuniteit in een 
endemisch gebied mogelijk verhindert, is het aan te bevelen om tegelijkertijd een 
effectief merozoieten-vaccin toe te dienen. 
Uit de bevinding dat het aantal AIDS-patiënten in Nederland belangrijk achterblijft 
bij de prognoses gemaakt aan het begin van de epidemie, kan niet worden geconclu-
deerd dat de omstreeks 1985 gestarte preventie-campagnes effectief zijn geweest. 
Anno 1994 is de mantel der ziekte waarmee men werkloosheid en arbeidsconflicten 
ruimhartig placht toe te dekken, gekrompen tot een nauwelijL· verhullend schaam-
lapje. 
Onder tortuur zegt het slachtoffer niet alleen wat de inquisiteur wil horen, maar ook 
dat waarmee hij denkt hem een genoegen te doen, omdat er een verbond ontstaat tus-
sen de twee. 
Father William of Baskerville. 
Eenmaal geproefd, na toevoeging van slechts enkele kruiden, zou NNN-medium wel-
eens een smakelijk tussen-gerecht kunnen blijken te zijn. 



